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ABSTRACT
In this study, numerical computations of the ocular fluid dynamics in a human eye
are presented with a perspective of understanding the mechanisms of increased flow
resistance. In the present study, the TM is represented as a multilayered-graded porous
structure with specific pore size and void fraction. The flow patterns and pressure
distribution in anterior chamber are analyzed to delineate key flow mechanism; the shear
stresses on the lens, iris and IW of SC are also examined to locate the maximum values.
Inside the human eye, the largest pressure drop occurs across JCT and IW of SC. The
highest pressure in SC is at the midpoint between two collector channels (CC). The
pressure falls near CC, which implies that the IW of SC will experience more pressure
difference towards CC, and the canal may show a greater tendency to collapse close to
the CC exits. The maximum velocity is found in the vicinity of IW pores. It is also seen
that AH velocity funneling out of the IW pores is higher in the region underlying the
collector. Analysis is also carried out for glaucomatous condition where the IOP is
increased to a high value of 8000 Pa.
The later part of thesis is dedicated to the drug delivery to the posterior segment
of the eye. The main objective of this study is to characterize the spatio-temporal
evolution of drug distribution following intravitreal injection into a vitreous substitute
such as silicone oil and in the case of vitreous liquefaction caused due to aging. Both
direct injection of drugs and injection of time-released drugs are studied. The results
show that the concentration distribution is highly dependent on the vitreous substitute,
diffusion coefficient of the drug and the permeability of the retinal surface. For drugs
with high diffusion coefficients, convection plays a small role whereas for the drugs with

xi

low diffusion coefficients and low viscosity vitreous fluids, convection is seen to play a
more important role and can lead to high drug concentrations on the retina, which can be
potentially toxic. Time-released drug injection is shown to avoid conditions of retinal
toxicity.

xii

CHAPTER 1. INTRODUCTION
1.1 Objective
The eye is a complex physiological system controlled by mechanical,
biochemical, and neurological factors, which, under normal conditions, maintain stability
and regulation of the intra-ocular pressure (IOP). This stability and regulation are
essential for the maintenance of the eye’s visual functions and for the nourishment of its
tissues. Understanding the details of the ocular fluid flow in the human eye is of interest
to ophthalmologists so that they can adapt treatment procedures in case of eye disease.
However, many aspects of fluid flow within the eye have not yet been fully examined or
quantitatively explained. Many difficulties occur for in-vivo experiments on human eye
because of their small size, low velocities, etc., and developing numerical models
constitutes an attractive approach to study the human eye.

Figure 1-1: Outflow path of Aqueous Humor in the human eye [1]
As represented in Fig. 1-1, aqueous humor (AH) is formed by secretion and ultrafiltration in the ciliary process, which are highly vascularized ridges projected from the
ciliary body towards the posterior chamber. Aqueous humor enters the eye in the
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posterior chamber and passes between the lens and iris before entering the anterior
chamber through the pupil. The bulk flow rate in the normal eye varies in the range of 23 µL / min [5, 47]. More than 80% leaves through Trabecular Meshwork (TM) into the
Schlemm’s canal (SC), which is located in the vicinity of the junction between the iris
and the cornea, usually called as iridocorneal angle. The aqueous humor is then led into
the venous system, either in aqueous veins or episcleral veins. Another exit pathway for
aqueous humor is uveoscleral drainage system, whereby aqueous humor enters the iris
root and passes between the muscle bundles in the ciliary body to the choroids and out
through the episcleral tissues. This pathway contributes little part of the outflow in rabbit
eyes (20 %) but more in monkey eye (35 %), which is neglected in our human eye model
for the simplicity.
The blood flow in the iris and the ciliary body maintains the temperature of these
tissues at the body temperature (37 ˚C) [9]. The outer surface of the cornea (0.6 mm
thick) [54] is generally maintained at 32-33 ˚C [9] by the tear film evaporation. The inner
corneal surface is at lower temperature, and is only 2-4 ˚C less than the body temperature
because of the thermal resistance provided by the corneal tissues. However, the small
temperature difference (2-4 ˚C) across the anterior chamber is believed to be the
dominant mechanism driving the fluid flow in the anterior chamber of the eye.
The outflow network system of the eye consists of a graded porous mesh from the
inside of the eye to the outside. Aqueous in the trabecular outflow encounters a series of
narrow passages that offers resistance to its flow; first the uveal portion of the TM; then,
in succession, the corneoscleral portion of the meshwork; the juxtacanalicular tissue
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(JCT); and the Inner wall (IW) of Schlemm’s canal (SC) from where the aqueous humor
is drained into aqueous veins [11,54].
Most of the diseases associated with the eye are consequence of increase in IOP
inside the anterior chamber. The blockage of the eye-drainage system raises the IOP to
abnormal values, which leads to Glaucoma. It is surprising that, despite many years of
research, precise reasons for increase in aqueous outflow resistance is not known, which
implies that the fundamental factors controlling the IOP is not still well understood.
Recently two main schools of thought have emerged. One states that extra-cellular matrix
(ECM) within the JCT is responsible for the bulk outflow resistance [4, 30]. The other
states that the cells within the aqueous outflow pathways, most likely the cells of the IW
of SC [6, 30], are themselves directly responsible for the aqueous outflow resistance.
The existing numerical models for the flow field inside the eye are incapable of
analyzing the influence of the TM-IW resistance on the IOP and AH-flow profile, which
is determining factor for all forms of Glaucoma. One of the purposes of this study is to
accurately model the TM and the IW of SC in order to obtain the major regions of flow
resistance or major sites of pressure drop. In this study, the following cases are presented:
(1) JCT as the source of resistance (JCT-R), (2) IW as the source of resistance (IW-R)
and (3) IW with distributed pores as the source of resistance (IWP-R). In summary our
main goal is to:
•

Present a comprehensive three-dimensional flow simulation where the details of the
TM are represented as a graded porous structure, and the flow patterns and the
pressure distribution in the anterior chamber for different parametric conditions are
analyzed to delineate the key flow mechanisms.
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•

Accurately model the JCT considering that the entire pressure drop occurs in this
region due to the aqueous humor particles deposited in the ECM of JCT.

•

Accurately model the IW endothelium of SC. IW of SC is modeled in such a way that
only 0.2% of its total area is open for the AH to pass through. The hydraulic
conductivity of these pores is very high but the hydraulic conductivity of these pores
is not reported yet. Funneling effect [15] observed in the IW is also demonstrated.

•

Study the effects of increased pressure in the anterior chamber i.e., for the case of
Glaucomatous eye where the IOP is greater than 8000 Pa.
The later part of thesis is concentrated on the drug delivery in the Vitrectomised

eyes. Currently, the treatment of retinal diseases is limited by the difficulty in delivering
effective doses of the drugs to target tissues in the vitreous chamber. Many drugs have a
narrow concentration window of effectiveness and may be toxic at higher concentrations
[32]. Therefore, the ability to predict local drug concentration is critical for proper drug
delivery. An intravitreal injection provides the most direct approach to delivering drugs
to the tissues in the vitreous segment, and therapeutic tissue drug levels can be achieved.
Intravitreal injections, however, have potential side effects of retinal detachment,
hemorrhage, endophthalmitis, and cataract. In many cases, repeated injections are needed
to maintain the effective range of drug concentrations for a certain period of time since
the half-life of drugs in the vitreous is relatively short. Repeated injections cause patient
discomfort and may further lead to complications such as vitreous hemorrhage, infection,
and lens or retinal injury. Therefore, an understanding of the transport of different drugs
following intravitreal injection is necessary, so that, the most effective utilization results
from each injection. In the present study, a time-dependent numerical model for studying
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drug transport following intravitreal injection is developed with the goal of understanding
the important parameters that play a critical role in the drug distribution.
Previously, the studies carried out by some researchers assumed that the vitreous
body was filled with vitreous humor. One of the more recent developments in eye surgery
has been the introduction of the surgical procedure called vitrectomy. Trans pars plana
vitrectomy (TPPV) is used to treat many different retinal disorders such as proliferative
diabetic retinopathy (including vitreous hemorrhage), macular hole formation, intraocular
infections (endophthalmitis), etc. In TPPV, the vitreous is removed and replaced with
vitreous substitutes similar to the liquid being removed from the eye. Silicone oil,
fluorosilicone oil, perfluorocarbon liquid, etc., are the most commonly used vitreous
substitutes [41-42]. Retinal tears are often associated with age-related liquefaction and
shrinkage of the vitreous body. In these cases, the vitreous substitutes can be used intraoperatively to push a detached retina to its normal position and to restore the volume of
the vitreous cavity. When the drug is injected into the vitreous cavity, knowledge of the
drug distribution following injection is very important in order to maximize the
therapeutic benefits while minimizing damage to tissues due to high local concentration.
This is highlighted by a study by Stainer et al. [43] and Hegazy et al. [44] who have
shown that the concentration of drug that is non-toxic when injected into a normal eye
and is toxic if used to treat a vitrectomised eye. Thus, it can be potentially dangerous to
use the knowledge base for a normal eye to treat the vitrectomised eye, and it is important
to develop an understanding of the drug transport with vitreous substitutes.
The goal of the present work is to simulate intravitreal drug delivery in the
presence of vitreous substitutes. There is limited information available on intravitreal
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drug distribution in the normal eye and is based on the studies carried out by Friedrich et
al. [36-37], Park et al. [80], Stay et al. [33] and Xu [38]. However, there is no information
available on how the drug is transported in the presence of vitreous substitutes that have
different transport properties. In the present study, a time-dependent numerical model for
studying drug transport following intravitreal injection is developed with the goal of
understanding the important parameters that play a critical role in the drug distribution.
The concentration distribution of drug is highly dependent on the vitreous substitute,
diffusion coefficient of the drug and the permeability of the retinal surface. A parameter
of specific interest is the diffusivity of the drug since different drugs are characterized by
different scalar diffusivity. So drugs with different diffusion co-efficient i.e., high and
low diffusion co-efficient are studied. In the present study, silicon oil is used an
intravitreal substitute and drug distribution as a function of time is examined. Both direct
injection of drugs and injection of a time released drug distribution are studied.
Another problem associated with the vitreous is the liquefaction of vitreous
humor. In humans, aging brings important changes in the rheological characteristics and
the nature of the vitreous. From the age of 45-50 years, the volume of the gel-vitreous in
the human eyes decreases steadily, and the volume of the liquid-vitreous proportionally
increases. This has been observed with slit lamp investigation carried out by Eisner [46]
with direct measurement of the liquid vitreous in formalin-fixed eyes. Thus, due to
vitreous liquefaction with aging, fluid circulation is expected in the vitreous chamber
leading to a reduction of gradients in the drug concentration within the liquefied portion.
This will lead to the reduced half life of the drug in the vitreous chamber. Therefore, in

6

the present study, we have also included water as one of the vitreous fluids in order to
compute the drug transport for the case of liquefied vitreous.
1.2 Literature Survey
Computational modeling of complex drainage system of eye and obtaining an
insight in the variation of IOP for various pathological conditions is an extremely
complicated problem. Several models have been previously reported to explore the
temperature distribution and flow mechanism inside the anterior chamber of eye, but
these models are limited due to many assumptions and simplifications. These models are
focused on analyzing either only the JCT or only the SC, but a complete threedimensional model with the effect of IW of SC on IOP is still to be addressed.
In 1983, Johnson et al. [5] proposed a mathematical model of Schlemm’s canal to
simulate the collapse of the canal and its resistive effect on the aqueous outflow. Their
theoretical model is focused on the analysis of two principle sites of resistance,
Schlemm’s canal and Inner wall of Schlemm’s canal. In their flow model, the aqueous
humor flows from the TM through the inner wall, into the Schlemm’s canal, and along
the canal in the circumferential direction, and finally exits through a number of spaced
collector channels. They modeled the TM as a series of linear springs that allow the inner
wall to deform in proportion to the local pressure drop across it. In their model the inner
wall is supported by the meshwork attachment and is flexible in accordance with the
pressure changes, while the outer wall is assumed rigid. They concluded that most of the
resistance in the aqueous outflow network occurs along the inner wall of the Schlemm’s
canal, and Glaucoma is a consequence of the collapse of the Schlemm’s canal alone.
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They completely ignored the effect of JCT on the outflow resistance, which is considered
by a number of investigators to be most important site of the outflow resistance.
Later Ethier et al. in 1986 [4] developed a model to determine the relation
between the resistance of the meshwork with the concentration of the extra-cellular
matrix- gel of JCT. They proposed two computational models that could predict the flow
resistance of the JCT. In the first model they described the JCT as a porous medium
permeated by open spaces (pores) through which AH flows. This model under predicts
the resistance of JCT by a factor of 10-100, which suggests that the gel, which fills the
open spaces of JCT, may control the resistance of the tissue. In the second model open
spaces of the JCT is filled with a GAG gel for predicting the flow resistance of the gel.
This model showed that the measured bulk concentration of GAG gel was consistent with
gel concentrations needed to account for the estimated resistance of the JCM in-vivo. The
entire model is based on the analysis of the effect of gel-concentration on the JCT
resistance to outflow, but they did not focus on the flow field and related IOP.
In 1988, Scott [20] presented a mathematical model of human eye based on the
bio-heat heat transfer equation for calculating the intra-ocular temperature distribution.
They used the Galerkin finite element method for analyzing the sensitivity of the
temperature distribution in the unexposed eye to the uncertainties in the parameters
investigated, which includes thermal conductivities of the ocular tissues, the heat loss
from the anterior corneal surface to the surroundings by convection and evaporation and
the convective heat loss from the sclera to the body core. Scott extended this work to
calculate the temperature rise experienced by the intra-ocular media when exposed to
infrared radiation. The model is used to calculate transient and steady state temperature
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distributions for different exposure times and a range of incident irradiances. They did
not solve for the intra-ocular flow field, so their analysis of temperature rise is done
without inclusion of buoyancy, and therefore the model does not predict realistic
temperature rise.
Later in 1992, Johnson et al. [6] proposed a model to explore possible
hydrodynamic interactions between JCT and IW pores of the SC. In their study they have
considered the JCT and IW of SC as a coupled system to analyze the interaction between
these two important sites of outflow resistance. This interaction arises because the pores
in the IW endothelium are small and well separated. The flow is non-uniform in JCT and
preferentially directed towards the region, which are in vicinity of the pores of IW
endothelium, reducing the effective cross-section area available for the flow of aqueous
humor. This funneling interaction of the pores markedly increases the effective resistance
of the JCT by 30-fold. This increase was not due to the flow resistance of the IW but
rather the flow resistance was the result of a decrease in the effective area through which
the fluid must flow. They have determined a simple relationship for estimating the
magnitude of this effect as a function of the number of the pores and their size. Their
work is again limited to the analysis of pores and relation of their resistive effect with
respect to the other parts of the drainage system.
Canning et al. [9] solved the flow profile inside the anterior chamber using a
simplified three-dimensional computational model and analyzed the deposition of
particles leading to the formation of structures inside the eye. Their model show the
dominance of buoyancy on the flow field inside the anterior chamber and indicates that
only a small temperature difference is required to drive such flows. They analyzed the
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deposition of pigment particles on the corneal surface and formation of Krukenberg
Spindle; they used the criterion that pigment granules stuck to the ocular tissue if the
corneal shear stress at that location is less than a particular value. They estimated the
maximum possible size of Hyphema that could be formed at the bottom of the anterior
chamber by the sedimentation of erythrocytes in case of ocular trauma or rupture of blood
vessel. Depending on the balance of settling force and convective flow they determined
how far Hyphema could project upward into the flow before its constituents blood cells
are swept away by the flow. The absence of third dimension in their model limits the
visualization of real flow field. They did not consider the effect of TM and included lot of
simplifications in their model, which restrict their simulations to completely depict the
behavior of different particles inside the anterior chamber.
Heys et al. [7] presented a two-dimensional mathematical model of the coupled
aqueous humor-iris system that accounts for the passive iris deformation to the iris
contour. They modeled the aqueous humor as the Newtonian fluid and iris as linear
elastic solid. They solved the resulting coupled equation set by finite element method
with mesh motion in response to the iris displacement accomplished by tracking a
pseudo-solid overlying the aqueous humor. Their simulation for normal eyes shows that
the iris is displaced by the aqueous humor as it circulates through the anterior segment.
Their model predicts the iris contour and apparent iris lens contact, which is primarily a
function of the aqueous flow rate, the trabecular meshwork permeability, the permeability
of the posterior pathway and iris modulus. They modeled the blinking process by
applying a normal stress along the cornea. The model prediction of rise in IOP of eye
agrees with the experimental measurement on rabbit’s eye, but the shape of the pressure
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curve has poor agreement. They also predicted the smallest pressure difference (1Kpa)
between the anterior and posterior chamber of eye necessary to achieve the dramatic iris
contour observed in case of iris bombe. There are many simplifications in the model due
to the absence of the third dimension, symmetry about the center axis and neglecting the
buoyancy & gravity effect. The other major limitation of the model is that it includes only
a portion of the eye. Due to these simplifications, it is unable to accurately represent the
flow process.
Later in 2001, Heys and Barocas [18] have proposed a three-dimensional model
with a more realistic geometry of eye in which they have included the iris and posterior
chamber. They solved for the buoyancy driven ocular flow inside the posterior and
anterior chamber. They released the particles from the tip of the iris and the center of the
eye and observed their path inside the anterior chamber. They released few particles
evenly spaced on the inner circumference of the iris tip and predicted the formation of
Krukenberg Spindle based on the plot of particles residence time at different positions in
the coronal plane. Their results show two dark bands in the center of the eye, which
represent the location where particles circulated for the longest time. There are two outer
bands on the corneal surface which is additional region occupied by the particles for the
significant time. They compared these results with the simulations on the eye model with
higher temperature gradient across the anterior chamber and found less circulation of
particles near to the posterior surface of the cornea for high temperature gradient. Based
on these results they suggested that people living in the cooler climate might not develop
a spindle as distinct and heavily pigmented as the general population. Although their
model is three-dimensional and geometry is more realistic, they have neglected the effect
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of TM-resistance on deposition of particles, which play a major role in trapping, or
escaping of particles of different traits through TM-pores.
Later in 2003, Kumar et al. [10] carried out numerical simulations on a threedimensional model for the anterior chamber of rabbit eye to investigate the transport and
deposition of particles inside the eye. A geometrical porous-media model for the TM was
included in the simulations. The particle simulations for different particle types were
performed in a Lagrangian framework using the predicted AH flow field and pressure
distribution. Formation of three clinically observed structures, namely KS, Hyphema and
Hypopyon, were analyzed by using representative particles (pigmentary cells,
erythrocytes and leukocytes) of appropriate size and density. Corneal blood staining or
formation of clots on the iris surface, observed clinically for cases with distributed
sources of blood cells were also well predicted. Here TM was not modeled as a graded
porous filter and moreover the effects of IW endothelium of SC, SC and collector
channel were not taken into consideration.
A few recent studies have examined the transport of drugs injected in the vitreous
chamber. In 1991, Araie and Maurice [34] measured the distribution contours of
fluorescein and fluorescein glucuronide in the rabbit vitreous by freezing the eyeball and
sectioning it. In order to estimate the permeability of the retinal-blood barrier, a spherical
model was suggested, with the entire surface of the sphere representing the retina. It was
assumed that only diffusion occurred in the vitreous humor, and that the transport across
the retinal-blood barrier was proportional to the concentration gradient. Fitting the
experimental data with this model, they obtained the permeability values of the retinalblood barrier for different solutes. The concentration profile calculated by this model
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would be the same for any cross-section that passes through the center of the sphere, with
the highest concentration in the center and the lowest concentration next to the outer
surface. In a rabbit eye, the center of curvature of the retina is immediately next to the
lens, on the symmetry axis of the vitreous. Qualitatively, the concentration profile
calculated by a spherical model will be correct for the posterior hemisphere of the
vitreous that is behind the center of curvature of the retina. In a spherical geometry, the
concentration profile in the anterior hemisphere will be same as the posterior hemisphere,
because the two hemispheres are the same.
Later in 1992, Yoshida and Kojima [67] suggested another model where the
vitreous was simplified into anterior and posterior sections, and each section was further
divided into eight compartments, each consisting of a thin shell and a separate
permeability was used for the outer surface of each hemisphere. For each section, three
parameters were used to describe the model, inward and outward permeability of the
retinal-blood barrier and the diffusion coefficient of the vitreous humor. Assuming that
rapid movement of the solute occurred by diffusion alone, the concentration within each
compartment is uniform and can be calculated from the Fick’s law. They measured
concentration profile after intravitreous injection and fitted the experimental data to get
the inward and outward permeability. The profile predicted by a model which uses
concentric compartmental shells will always have concentration contours that are parallel
to the retina, because the concentration within each compartmental shell must be uniform.
Because of the simplified geometry, this model can only be applied for a situation when
the concentration contours are parallel to retina.
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In 1994, Tojo and Ohtori [35] proposed another model to describe the distribution
of the drug in the vitreous humor. They assumed that the vitreous body was a part of a
cylinder and the surface was divided into three areas, characterized by the drugelimination pathways: the retina-choroid membrane, which was represented by the
bottom and the curved surface of the cylinder; the lens, which was modeled by the center
of the upper surface; and the hyaloid membrane represented by the annular gap between
the lens and the retina. They developed a general mathematical model based on Fick’s
second law of diffusion describing the pharmacokinetics of the intravitreal injection of
dexamenthasone sodium m-sulfobenzonate (DMSB). They found that for the drug, the
retina-choroid-sclera membrane act as a major route of elimination and also concluded
that concentration on the surface of the retina is appreciably affected by the site of
injection or the initial distribution profiles.
Friedich et al. [36] used a finite element analysis to solve the mass transfer
problem in the vitreous humor of rabbit eye. They assumed that the vitreous was stagnant
and the mass transfer occurred by diffusion. Posterior segment of the eye was considered
in the model. They studied the effects of different parameters that effect the concentration
distribution in the vitreous humor, including the diffusion coefficient of the vitreous
humor, the permeability of the retinal-blood barrier, the injection positions. Permeability
of different compounds like fluorescein and fluorescein glucuronide through the retina
was determined by fitting the model predictions to experimental data.
In a human eye, the lens occupies a smaller portion of the vitreous than in the
rabbit eye. The volume of the vitreous humor in the human eye is approximately 4 mL,
and the volume of rabbit vitreous is approximately 1.5 mL. Therefore, Friedich et al. [37]
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extended their work by considering human eye model. Injections containing an equal
mass of drug dissolved in volumes of either 15 µL or 100 µL were compared. They also
studied the effects of different parameters that effect the concentration distribution in the
vitreous humor, including the diffusion coefficient of the vitreous humor and the different
injection positions. Initial position of the drug was assumed to be spherical in shape.
Controlled release of a therapeutic agent from a biodegradable polymeric system
presents an improvement to traditional direct-injection treatment strategies that can
overcome some of the problems associated with direct drug delivery. Controlled drug
delivery systems are designed for long-term administration in which the drug level
remains constant, between the desired maximum and minimum level, for an extended
period of time. Xu [38] developed a two dimensional convection-diffusion transport
model of the drug released from a localized source. The vitreous body was modeled as a
porous media and the drug injection site was considered to be cylindrical in shape. Stay et
al. [33] developed a three dimensional transport model of the drug following intravitreal
injection from a point source. Missel [39] studied bolus injection and drug delivery from
intravitreal devices for a rabbit eye model. In all these studies, the convection driven by
the pressure drop across the vitreous was taken into account, but with a porous media
model for the vitreous. Park et al. [40] developed a three dimensional finite element
method to simulate drug transport in the entire rabbit eye following the drug
administration by intravitreal injection through a controlled release implant.
1.3 Outline of the Thesis
This first chapter of the present report contained an introduction and literature
survey. The introduction part is an outline of the present work, which explains the
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problem of interest and the simulations performed in a brief form. The literature survey
portion is devoted to present the summary of the previous work done in the field of
aqueous humor dynamics and drug delivery to the retina.
The second chapter contains the explanation of anatomy of the eye. It is important
to understand the framework of eye, the functioning of its different constituents and the
different terminologies used frequently in the context of human eye. This chapter
includes all the required details of the eye to understand the present work. This chapter
also includes dedicated explanation of the vitrectomy surgery: its causes, current
treatment. It also discusses the role of different vitreous substitutes and the classification
of vitreous substitutes.
The third chapter is focused on explaining the mathematical and computational
model used for the simulations on the eye. The geometry used to represent the ocular
tissues and the governing equations, which could predict the ocular fluid dynamics, is
explained in detail. Emphasis is given to explain the strategy to accurately model the TM
and its interaction with IW of SC. Finally the boundary conditions used on the ocular
tissues to properly represent the environmental conditions of eye and numerical
procedure used to solve the governing equations is explained. This chapter also includes
the results of the simulations performed and the conclusions drawn.
The fourth chapter is devoted on explaining the effects of different methods of
drug delivery in the vitrectomised eye. In order to assess the effectiveness of the injected
drug, it is critical to know the drug distribution within the eye following injection. This is
particularly important when the vitreous medium has been replaced by fluid substitutes
since there is little understanding of the transport of drugs in vitreous substitutes. The
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main objective of this study is therefore to characterize the drug distribution following
intravitreal injection in the vitreous chamber of the human eye with different vitreous
substitutes.
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CHAPTER 2. ANATOMY OF THE EYE

Figure 2-1: Schematic diagram of the eye [68]
The eye globe, approximately spherical in shape, is recessed in the pyramidal
shaped bony orbit, and it is connected to the brain by optic nerves. The posterior fivesixth of the globe is covered by external white and opaque protective coat, sclera. The
remaining anterior one-sixth of the globe consists of a uniquely transparent, convex,
protective fibrous structure, the cornea, which is responsible for the refractive incident
rays on eye. The limbus marks the transition between the cornea and sclera, Fig. 2-1. The
extra-ocular muscles, which originate into the bony orbit and insert into the sclera, are
responsible for the directional movement of the globe. The eyelids provide mechanical
protection to the globe, and they interrupt and limit the amount of light entering the eye;
they harbor the tear secreting glands and distribute the tear fluid over the anterior surface
of the globe.
Interposed between the retina and the sclera is vascular tunic of the choroids
which primarily supplies nutrients to the retina. Anteriorly, the choroids continue to the
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ciliary body, which is responsible for the formation of intraocular fluid, for providing the
distal attachment of the zonular fibers of the crystalline lens, and for harboring the
smooth muscles. The ciliary body continues anteriorly as the iris, a diaphragm with
around contractile opening, the pupil. With its variable diameter, the pupil acting like an
automatically adjustable aperture of camera allows rays of light to fall on the retina. The
choroids, ciliary body and iris together constitute the uvea.

Figure 2-2: Diagrammatic meridional section through the human eye ball [54]
The anterior chamber, an elliptical space between the iris diaphragm and the
cornea, acts as a reservoir for a clear, watery fluid, the aqueous humor. In conjunction
with the outer fibrous tunic of the eye, the distended, stable dimensions of the globe are
maintained largely by the hydro-mechanical properties of this fluid. The aqueous humor
is formed continuously by the ciliary processes in the posterior chamber behind the iris
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and flows into the anterior chamber via the pupil; it finally leaves the eye through the
intricate system of outflow channels located in the corneoscleral limbus. The resistance
encountered during the passage and rate of aqueous humor production is the principal
factors determining the level of intraocular pressure. Additionally, this fluid acts as
carriers of nutrients, substrates, metabolites and waste products.
The larger posterior chamber of the eye is filled with a transparent, delicate
connective tissue gel, and the vitreous humor. The anterior face of the vitreous is
hollowed to accommodate the biconvex crystalline lens. The lens, situated behind the iris
diaphragm, is supported by suspensory ligaments, also referred to as the zonules that
extend between the ciliary body and the lens surface. The lax state of the zonules is
imparted by the contraction of the ciliary muscles together with the inherent plasticity of
the lens. The lens has the capacity to accommodate to focus outside images clearly to the
retina.
2.1 Geometrical Dimensions of the Eyeball
Although the eyeball is referred to as a globe, it is only approximately spherical
and consists of segment of two spheres placed one in front of the other. The anterior
corneal portion is smaller and more curved than the posterior, has a radius of curvature of
about 8 mm, and comprises one-sixth of the surface area of the eye. The cornea is
elliptical, with its vertical axis shorter than the horizontal one. The posterior scleral
portion is flatter, has a radius of curvature of about 12 mm, and comprises the remaining
five-sixths of the ocular surface area.
The anterior and posterior poles are the central points of the corneal and scleral
curvatures respectively; the line joining these two poles is the geometric axis. The
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external geometric axis is measured from the anterior surface of the cornea to the external
surface of the sclera, whereas the internal geometric axis is measured only to the anterior
surface of the retina. The three diameters of the globe are the sagittal (anterior-posterior),
transverse and vertical.
Histologic sections of the globe can be made in several planes. The meridional
plane passes through the anterior and posterior poles of the eye and may be vertical,
horizontal or oblique. Sagittal planes lie on either side of the meridional plane and are
parallel to it. The equatorial plane is midway between the anterior and posterior poles and
is perpendicular to the meridional plane. Sections parallel to the equatorial plane, whether
passing anterior or posterior to it, are called transverse, coronal, frontal, or radial planes.
The dimensions of adult human eyes are relatively constant, the average diameters
are 24 mm antero-posteriorly (sagittal diameter), 23 mm vertically and 23.5 mm
horizontally [54]. The sagittal diameter may vary most, ranging from 21 to 26 mm in
normal eyes. With a high degree of axial myopia, the sagittal diameter may be as large as
29 mm; with hypermertopia, it may be as small as 20 mm. The transverse and vertical
diameters are less variable with a range of 23 to 25 mm. The circumference of human eye
is about 75mm. Overall, the male eye is about 0.5 mm larger than the female eye and the
Negro eye is said to be somewhat larger than those of white races. The eye of the
newborn is more spherical than the adult eye, and therefore more hypermeteropic, with a
sagittal diameter of 16 to 17 mm; this increases rapidly in size to 22-23 by thee years of
age. A further increase of about 1 mm occurs between 3 to 13 years, but there after little
growth takes place. The eyeball weighs about 7.5 gm, its volume is about 6.5 ml, and its
specific gravity varies from 1.002 to 1.009.
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2.2 Tunics of the Eyeball

Figure 2-3: The antero-nasal portion of a horizontal (meridional) section of human eye
The eyeball, bisected along a meridian, discloses the fundamental architectural plan of
the globe, Fig 2-3. The three tunics of the eyeball revealed are the fibrous coat, the uveal
tract, and the retina. The external tough fibrous coat is formed by the sclera, which is
continuous anteriorly with the cornea and posteriorly with the meningeal covering of the
optic nerve. The uveal tract, a highly vascular layer, forms the middle pigmented tunic
and is in contact with the sclera. The anterior portion of the uveal tract, the iris, forms a
partition subdividing the interior of the eye. The central opening of this diaphragm, the
pupil is the aperture of the optical system. The retina forms the whitish, inner tunic of the
eyeball and is in contact with the choroid. The nerve fiber layer of the retina continues
posteriorly as the optic nerve.
2.2.1 The Fibrous Tunic
The fibrous coat protects the more delicate inner structures and, when distended
by the intra-ocular pressure, gives the eyeball its definite shape. Tightly packed
collagenous connective-tissue fibers, elastic fibers in much smaller numbers, and
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relatively few stroma cells, are the tissue elements that impart strength and resistance to
the fibrous coat. Fibrous tunics consist of the following layers:
•

The Sclera
The sclera is an opaque, dull white, dense, visco-elastic and resilient outer coat of

the eye, which occupies the posterior five-sixth of the globe. In the sclera the tissue
elements are arranged into lamellae or broad ribbons which interweave in intricate,
strength-increasing patterns. In the most anterior portion of the sclera the fiber bundles
run parallel to the limbus; at the equator a meridional course prevails, while crossings of
the ribbons at right angles are characteristic of the posterior half. Around the exit of the
optic nerve, nasal to the posterior pole, circular fiber-bundles predominate. The thickness
of the sclera varies from half a millimeter at the equator to a millimeter or more at the
exit of the optic nerve. The outermost layers of the sclera, especially anteriorly, are
relatively loosely woven and contain more numerous blood vessels.
•

The Cornea

Figure 2-4: Layers of Cornea [69]
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The cornea consists of a clear, transparent, avascular, visco-elastic tissue with a
smooth, convex external surface and a concave internal surface. It occupies one sixth (1.3
cm2) of the total surface area of the fibrous coat of the globe. The main function of the
cornea is optical; it forms the principal refracting surface of the dioptric system of the
eye. Anteriorly, when the lids are open, the cornea is separated from the air only by the
pre-corneal tear film (6-20µm thick), which imparts the characteristic brilliant luster. The
tear film is a physiologic secretion that covers the external surface of the corneal
epithelium and, strictly speaking, is not an anatomic part of the cornea. It is divisible into
three layers. (a) The anterior oily layer, less than 0.5 µm thick, is derived from the
sebaceous glands of the lid and caruncle. (b) The middle aqueous layer, 5-18 µm thick,
represents the secretion of the lacrimal glands and dissolved proteins. (c) The posterior
mucoid layer (0.5 µm thick), rich in glycol-proteins, is derived from the conjunctival
goblet cells. By filling minor surface irregularities, the tear film provides a smooth
air/cornea interface for refraction of light. The pre-corneal tear film is the main vehicle
for the supply of nourishment to the corneal epithelium and for removal of detritus. The
movements of the lids replenish the integrity of the tear film and, if the inter-blinking
time is prolonged more than half a minute, breaks in the tear film may appear (the socalled tear break-up time). Viewed anteriorly in vivo, the cornea is a meniscus elliptical
in shape because of the greater extension of the less transparent limbus above and below
it. Therefore, the vertical corneal diameter is smaller than the horizontal diameter (10.6
mm and 11.7 mm respectively in males); in females, each is 0.1 mm smaller. The anterior
curvature of the cornea (radius of curvature 7.8 mm) is greater than that of the sclera
(radius of curvature 11.5 mm). Nevertheless, the cornea does not protrude much beyond
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the scleral surface, because of the flattening of the anterior sclera and peripheral cornea
and the sinking effect of the external scleral. In the central or optical zone (approximately
4 mm in diameter), the two surfaces of the cornea are parallel, and the cornea is nearly
spherical except for a small amount of astigmatism (the surface is more curved in the
vertical than in the horizontal meridian), which gives it a toric form.
Viewed posteriorly, the cornea is circular, with a diameter of 11.7 mm and with
an average radius of curvature of 6.5 mm. Measured by optical methods, the cornea in
vivo is 0.52 mm thick centrally with little difference between males and females.
Towards the periphery, the cornea thickens to 0.97 mm and merges with the conjunctiva,
episclera, and sclera. The weight of the freshly excised cornea is approximately 180 mg
and the specific gravity is 1.052.
Structurally (Fig. 2-4), the cornea consists of: (1) Epithelial layer with its
basement membrane; (2) Stroma with its anterior modified zone of Bowman; (3)
Descemet's membrane, which in fact is the basement membrane of the corneal
endothelium; and (4) Endothelium ( Mesothelium).
•

The Corneoscleral Junction
The limbus is the gray transitional zone between the transparent cornea anteriorly

and the opaque, white sclera posteriorly, Fig.2-3. It is here the smaller corneal curvature
merges with the greater curvature of the sclera; this region is often referred to as the
corneoscleral sulcus. Unlike the circular profile of the posterior corneal periphery, the
anterior cornea is horizontally elliptical in shape. The sclera therefore extends forward in
the superior and inferior regions in the medial and the lateral aspects. This gives rise to
the slightly wider zone of the limbus in the vertical plane (2 mm) than in the horizontal
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plane (1.5 mm). The transitional zone of the limbus is composed of both scleral and
corneal elements, the contribution of each varying from superficial to deep regions and
also in the various sectors around the circumference of the limbus. The limbus can be
divided into three separate zones.
The anterior limbus is the part of limbus consisting of the conjunctival epithelium
and the stroma that contains the episcleral and subconjunctival vascular plexuses and
loose fibrous tissue of the episclera. The mid-limbus consists of compact corneoscleral
tissue and traversed by the veins of the deep and intrascleral plexus and by small
arterioral channels and nerves. The inner deep limbus contains the trabecular meshwork
and Schelmm’s canal, as well as related arterial and venous plexuses. The deep limbus
contains:

Figure 2-5: Drainage system of eye. (a) SC- Schlemm canal, (b) TM- Trabecular
Meshwork, (c) C- Cornea (d) IS- Interscleral vascular channels (e) DM –Descemet’s
membrane, (f) SS- Scleral spur, (g) CB- Ciliary body, (h) IR- Iris (From Tripathi and
Tripathi [54]).
(1) Trabecular Meshwork:
The trabecular meshwork is a triangular-shaped wedge of tissue that encircles the
anterior chamber and has its apex located at the peripheral terminus of the Descemet’s
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membrane (Schwalbe’s line). From this anterior boundary, the meshwork expands as it
bridges the irido-corneal angle of the eye and ends posteriorly by blending with the
storma of the iris, ciliary body, and scleral spur. The scleral spur projects like a shelf into
the meshwork at its posterior margin, and serves as a point of insertion for the
longitudinal bundle of the ciliary muscle (Fig. 2-5). The trabecular meshwork is
composed of a number of superimposed fibrocellular sheets and hence it presents a
trabeculated and reticular appearance. It surrounds the eye in an annular shape and forms
a three-sided prismatic band. The outermost trabecular sheet borders the tissues of
Schlemm's canal; the inner aspect of the trabecular meshwork directly borders on the
anterior chamber (Fig. 2-5). For descriptive purposes, the meshwork can be divided into:
iris processes or "pectinate" fibers, uveal trabeculae (also called ciliary, ciliocorneal, or
uveocorneal trabeculae), corneoscleral (also called sclerocorneal or scleral) trabeculae
and juxtacanalicular tissue (JCT). The iris processes are large, wide bands that arise from
the anterior surfaces of the iris and join midway in the inner uveal trabeculae.

Figure 2-6: Detailed view of Uveal side of TM
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The uveal (Fig. 2-6) and corneoscleral portions of the trabecular meshwork have
an approximately analogous structure. Both are composed of series of trabeculae or
beams that delimit a system of aqueous flow channels. At the base, the number of
trabecular sheets varies from 12 to 20, but toward the apex they are reduced to 3 to 5
layers. The flow channels become progressively smaller from the uveal to the
corneoscleral meshwork. The inner 1-2 layers of uveal sheets closest to the anterior
chamber, however, have a round, cord-like, profile and are oriented predominantly in a
radial, net-like fashion enclosing large oval, circular, or rhomboidal spaces. The
corneoscleral trabeculae are flattened, perforated sheets, the individual layers being 5 to
12 µm thick in the mid region. In man, their number may vary from 8 to 15 layers,
measuring from 120 to 150 µm in total thickness. The intra-trabecular spaces vary in size
from 25 to 75 µm in the uveal meshwork and from 2 to 20 µm in the outer corneoscleral
meshwork. In one of the analysis Grant et al. [70] confirmed that the number and size of
these openings are such that the uveal meshwork can be expected to create negligible
resistance of flow. Collapse of the trabecular meshwork, as occurs in hypotony, thus
reduces the effective area of the openings. The trabecular cells are phagocytic [29]. They
are capable of ingesting both endogenous materials such as pigment [29] and hemolyzed
erythrocytes and exogenous material such as latex micro-spheres, presumably for the
purpose of keeping the trabecular outflow free of potentially obstructive debris.
The JCT, also known as pericanalicular region or cribriform area, intervenes
between the first (outermost) corneoscleral trabecular beam and the discontinuous
basement membrane of the inner wall of the canal of Schlemm (IW of SC). The thickness
of this region varies from 2 to 20 µm. It is believed that the tortuous flow passage from
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the JCT accounts for the most of the flow resistance [6] because of its very small pore
size approximately 0.1-3.0µm [30] and the presence of the extra-cellular matrix gel in the
open spaces. In human eyes studied in vitro by Johnson et al. [71], approximately 50 %
of 0.18 particles were caught in the trabecular meshwork and especially in the JCT tissue
when perfused through this region. Bill et al. [24] further speculated that with increasing
age, increased cross linking may occur as part of the process, leading to accumulation of
extra-cellular material in the JCT tissue, increased outflow resistance, and ultimately to
the development of glaucoma. However, morphologic evidence for such an
accumulation, sufficient to generate a significant outflow resistance, is still lacking. The
porosity of the meshwork is increased when the trabeculae are separated, as occurs with
the contraction of the ciliary muscle and the posterior pull of the scleral spur. Such
mechanisms are important in the treatment of glaucoma.
(2) Schlemm’s canal:
The canal of Schlemm (SC) is an annular structure of about 36 mm circumference
in the human eye, Fig 2-7. Located in the inner part of the limbus, it is supported on its
inner aspect by the trabecular meshwork. Anteriorly, it is bound by the compact scleral
tissue; posteriorly, it lies against the main mass of the corneoscleral trabeculae. Laterally,
the canal is bordered by the scleral spur and scleral roll, and medially it is limited by the
approximation of the first trabecular sheet with the compact corneoscleral tissue of the
limbus. The lumen of the canal is usually an elongated, slit-like opening that lies parallel
to the corneoscleral trabeculae. Its dimensions vary from eye to eye; in the adult eye,
when a single lumen is present, it measures 200-500 µm in the meridional axis and 10 to
25 µm in the opposite axis; it is generally smaller in children. In some instances, the
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canal may be triangular in m. shape with the base of the triangle lying against the scleral
spur, where it measures 50 µm in width, whereas the apex narrows medially to 5-10 µm.
Aqueous humor is drained away from the canal of Schlemm, Fig. 2-7 by the three venous
plexuses: the deep intra-scleral, mid-intrascleral, and episcleral and sub-conjunctival. The
lumen of the canal is connected to the deep scleral plexus by 25 to 35 collector channels

Figure 2-7: Canal of Schlemm and its communication with collector channels, aqueous
veins and intrascleral venous plexus [54]
distributed unevenly around the circumference of the canal. The channels are relatively
wide when they arise at the canal (diameter, 20-90 µm), but become narrower as they
anastomose with the venous channels. The collector channels join the deep scleral plexus,
which is made up of fine branches of the anterior ciliary veins. The deep scleral plexus, in
turn, is connected to the mid-intrascleral and episcleral plexuses. The mid-intrascleral
plexus is formed by a large interconnecting venous network in the limbal sclera; in
addition to receiving blood from the deep scleral plexus, it drains the ciliary venous
plexus. Posteriorly, the intrascleral plexus drains into the episcleral plexus and finally
into the anterior ciliary veins, Fig. 2-7. A few vessels, known as aqueous veins, varying
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in number from 2 to 8, arise from the canal of Schlemm and directly join the episcleral
plexus. A variable amount of aqueous humor reaches the episcleral veins directly via the
aqueous veins. Where an aqueous vein joins a blood vessel, the aqueous humor and blood
do not mix immediately, but flow in parallel streams to give a laminated aqueous vein.

(a)

(b)

(c)

(d)
Figure 2-8: (a) Schematic drawing showing the vacuoles in the IW of SC, (b) Scanning
Electron micrographs of the endothelial lining of the wall of SC viewed from the luminal
aspect. Note the spindle shaped appearance of the cells with apical bulges in the central
region correspond to the nuclear and macro-vacuolar structures (V), (c) A vacuole in
endothelium lining the inner wall of SC in a control eye.(d) A pore is seen in the vacuole
opening both towards the meshwork side and the lumen side [22].
A characteristic feature of the IW of SC (Fig. 2-8) is its tendency to form large

out-pounchings in to SC, called the giant vacuoles. This nomenclature is perhaps
misleading, since the giant vacuoles are not intercellular structures, but instead represents
deformations of the inner wall endothelial cells that create a small potential space
between the extra-cellular material of the JCT and the inner wall of cell. Giant vacuoles
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are pressure-sensitive structures in the endothelial lining of Schlemm’s canal. They
respond rapidly to changes in the IOP, largely disappearing in <=3min [14] after the IOP
is reduced to zero in enucleated eyes. Tripathi [54] suggested that giant vacuoles
represent the mechanism of fluid transfer across the endothelial lining of Schlemm’s
canal. Changes in IOP are unavoidable in vivo, for example due to normal diurnal
variation and/or occasional ocular massage. Changes in IOP significantly affect giant
vacuole density, and subject inner wall cells experience variable and transient ‘stretching’
throughout the day. Grierson and Lee [12] showed that as the pressure increases from 8
to 30 mmHg in the rhesus monkey eye, the net area of inner wall cells increases by more
than 50% due to giant vacuole out-pounching. This amount of stretching, as shown in
Fig. 2-9 (c), is unusual for endothelial cells elsewhere in the body, and in fact stretches of
order 50 % cause immediate damage to cultured bovine aortic endothelial cells, as
measured by the loss of ability to exclude propidium iodide [28]. It seems likely therefore
that the inner wall of SC is somehow adapted to deal with such large deformations.
In an extensive study, Ethier et al. [23], found that there are two distinct kinds of
pores present in the IW endothelium namely the Intracellular pores (i.e., passing through
the cells) and Paracellular pores (i.e., passing between the cells). There are structures
such as endothelial tubules or also called as septae, the purpose of these structures is to
prevent the complete collapse of Schlemm's canal, which would otherwise occur when
ever the pressure got too high.
All vacuoles open towards the meshwork side and some, but not all, are open
towards the SC side. The diameter of most openings towards the trabecular side was
about 3.5 µm while towards the schlemm’s canal side it was around 1-1.8 µm . Bill and
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Svendbergh et. al. [24], in a meticulous study using SEM found that in human that the IW
SC contains 1840 pores/mm2. At elevated IOP there are around 20,000 pores in inner
wall of SC of human eye but according to Johnson [66] only 13 to 29 % of vacuoles have
pores on both ends. At higher IOP increase in the number of vacuoles can cause SC to
collapse as shown above in Fig. 2-9. Parc et al. [26] found in their experiments that giant

(b)

(a)
Low IOP

High IOP

Sclera

Inner Wall
of SC
(c)

(d)

Figure 2-9: (a) Transmission electron micrographs showing the vacuoles in the IW of SC,
(b) Erythrocytes which are trapped in the IW endothelium [22], (c) & (d) Composite
schematic drawing of the TM and SC of the human eye at lower and higher IOP.
vacuoles are preferentially found near collector channels, indicating that aqueous flow
across the inner wall is sensitive to downstream pressure. Darryl et. al. [16] cited that the
pores in the IW endothelium of SC cause the funneling effect. Flow through JCT is
confined to regions near the inner wall pores, forcing a funneling pattern of aqueous
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streamlines, as illustrated in the figure above. The reduction in the available area for flow
increases the effective outflow resistance.
(3) Scleral spur and scleral roll:
The scleral spur is a firm, fibrous, wedge-shaped ridge or projection from the
inner aspect of the anterior sclera and is oriented circumferentially in the inner limbus.

Figure 2-10: An illustration of the streamlines of aqueous flow through the JCT before
(A) and after (B) washout [16]
(4) Line of Schwalbe:
A prominent anterior border ring of the trabecular region, called the line of
Schwalbe, is seen in only about 15-20% of human eyes. The line of Schwalbe consists of
regular collagen fibrils intermixed with elastic fibers, both being oriented parallel to the
limbus, somewhat similar to the uveal trabeculae.
2.2.2

The Uveal Tract
The uveal tract forms the pigmented vascular tunic of the eye. It may be divided

topographically into three regions: (1) the choroid, (2) the ciliary body and (3) the iris.
•

The Choroid
The choroid, a soft, brown vascular tunic, is the posterior part of the uveal tract.

The choroid lies between the retina and sclera. It is composed of layers of blood vessels
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that nourish the back of the eye. The choroid connects with the ciliary body toward the
front of the eye and is attached to edges of the optic nerve at the back of the eye.
•

The Ciliary Body
The ciliary body is an anterior continuation of the choroid and of the retina and, as

such, is divisible into uveal and neuro-epithelial portions. The ciliary body forms a
circumferential, asymmetric girdle, slightly narrower on the nasal side and in the upper
part (4. 2 to 5.2 mm, respectively) than on the temporal side and lower part (5.5 to 6.3
mm, respectively). One function of the ciliary body is the production of aqueous humor,
the clear fluid that fills the front of the eye. It also controls accommodation by changing
the shape of the crystalline lens. As the ciliary body contracts, the zonules relaxes. This
allows the lens to thicken, increasing the eye's ability to focus up close. When looking at
a distant object, the ciliary body relaxes, causing the zonules to contract. The lens
becomes thinner, adjusting the eye's focus for distance vision.
•

The Iris
The iris is the most anterior portion of the uveal tract and forms a delicate

diaphragm between the anterior and posterior chambers of the eye. It has a central
aperture called the pupil, which is located slightly nasal from the center and controls the
amount of light entering the eye. It also provides communication for the free flow of
aqueous humor from the posterior into the anterior chamber. The iris is thickest close to
the pupillary zone in the region of the collarette and thinnest (0.5 mm) and weakest at its
root, from which it can easily be torn surgically or in contusion injuries (irido-dialysis).
The major portion of the iris rests on the anterior surface of the lens. In the absence of
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support from the lens, the pupillary plane falls back, the anterior chamber deepens, and
the iris becomes tremulous (irido-donesis) during the movements of the eye.
The color of the iris, which varies in different individuals, depends upon the
amount of pigment in the stromal cells. The stromal pigmentation increases rapidly
during the first year of life, and hence many infants who were born blue-eyed gradually
lose the lightness of their irises. An iris devoid of tromal pigmentation, but with a
normally pigmented bi-layered epithelium, will also appear blue. In the event of pigment
deficiency in the iris epithelium, the red fundal reflex gives the iris a pink color.
The diameter of the iris is about 12 mm. The anterior surface is divided into a
central (pupillary) zone and a peripheral (ciliary) zone. The junction of these two zones is
marked by the collarette (0.6 mm thick and 1.5 mm from the pupillary margin) and the
embryonic location of the minor circulus iridis which gives rise to the embryonic
pupillary membrane.
2.2.3

The Retina
The retina is approximately 0.5 mm thick and lines the back of the eye. The optic

nerve contains the ganglion cell axons running to the brain and, additionally, incoming
blood vessels that open into the retina to vascularize the retinal layers and neurons (Fig.
2-11). A radial section of a portion of the retina reveals that the ganglion cells (the output
neurons of the retina) lie innermost in the retina closest to the lens and front of the eye,
and the photo-sensors (the rods and cones) lie outermost in the retina against the pigment
epithelium and choroid. Light must, therefore, travel through the thickness of the retina
before striking and activating the rods and cones (Fig. 2-11). Subsequently the absorption
of photons by the visual pigment of the photoreceptors is translated into first a
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biochemical message and then an electrical message that can stimulate all the succeeding
neurons of the retina. The retinal message concerning the photic input and some
preliminary organization of the visual image into several forms of sensation are
transmitted to the brain from the spiking discharge pattern of the ganglion cells.
All vertebrate retinas are composed of three layers of nerve cell bodies and two
layers of synapses. The outer nuclear layer contains cell bodies of the rods and cones, the
inner nuclear layer contains cell bodies of the bipolar, horizontal and amacrine cells and

Figure 2-11: Schematic representation of retina [72]
the ganglion cell layer contains cell bodies of ganglion cells and displaced amacrine cells.
Dividing these nerve cell layers are two neuropils where synaptic contacts occur. The
first area of neuropil is the outer plexiform layer (OPL) where connections between rod
and cones, and vertically running bipolar cells and horizontally oriented horizontal cells
occur. The second neuropil of the retina, is the inner plexiform layer (IPL), and it
functions as a relay station for the vertical-information-carrying nerve cells, the bipolar
cells, to connect to ganglion cells. In addition, different varieties of horizontally- and
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vertically-directed amacrine cells, somehow interact in further networks to influence and
integrate the ganglion cell signals. It is at the culmination of all this neural processing in
the inner plexiform layer that the message concerning the visual image is transmitted to
the brain along the optic nerve.
2.3 Chambers of the Eyeball
2.3.1 Anterior Chamber
The anterior chamber of the human eye has an approximately ellipsoidal shape.
Its boundaries are formed anteriorly by the inner surface of the cornea and peripherally
by the inner surfaces of the trabecular meshwork. On the posterior aspect, the chamber is
limited by the anterior surface of the iris and the pupillary portion of the anterior lens
surface. On the lateral aspect, it ends in the anterior face of the ciliary body, where the
anterior and posterior boundaries meet, and where the apex of the angle of the anterior
chamber is located. Whereas the corneal endothelium forms a complete covering for the
chamber, the anterior surface of the iris, the anterior face of the ciliary body, and the
trabecular meshwork do not have a complete cellular covering; the anterior chamber thus
communicates directly with the extracellular spaces of these structures.
The size, shape, and depth of the anterior chamber are determined by the
curvature of the cornea, the shape of the iris, and the size and position of the lens. Since
the plane of the iris is not completely horizontal, because of the forward location of the
lens, the pupillary portion of the iris is displaced 0.6 to1 mm anteriorly with respect to the
iris root. This forward displacement of the pupillary plane, however, is smaller in myopic
than in hypermetropic eyes. The forward inclination of the iris and the pupillary sphincter
produces a ball-valve action, which offers some resistance to flow of aqueous humor
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from the posterior to the anterior chamber. During forceful contraction of the sphincter
muscle, the aqueous pressure in the posterior chamber may cause an anterior bowing of
the peripheral iris that produces "iris bombe". Pupillary dilatation or iridectomy may
reverse this situation.
The diameter of the anterior chamber varies between 11.3 to 12.4 mm and is
slightly greater than that of the cornea. Because of the corneal curvature, the chamber is
deepest centrally and shallower peripherally near the angle. The diameter of the cornea
and the depth of the anterior chamber are related. The chamber depth is slightly greater in
males than in females, but in both it decreases with advancing age as the size of the lens
increases. As a rule, the anterior chamber is shallower in hypermetropes and deeper in
myopes; on average, the central depth measures 3.15 mm (range, 2.6 to 4.4 mm). The
depth of the anterior chamber in the two eyes of the same individual is almost equal. The
anterior chamber is a reservoir for aqueous humor and, at any given time, contains about
250 µm of this fluid.
The aqueous humor is a clear, colorless watery solution continuously circulated
from the posterior chamber of the eye throughout the anterior chamber. The functions of
aqueous humor are as follows:
•

Carries oxygen and nutrients to the crystalline lens and posterior cornea since
these structures have no intrinsic vascular supply.

•

Similarly carries away the waste products from the above structures.

•

Helps to maintain the shape and internal structural arrangement of the eye by
contributing to the intraocular pressure.
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•

Serves as a mechanism to clear blood, macrophages, and products of
inflammation from the anterior segment of the eye.

Figure 2-12: Illustrating the current of aqueous humor from the ciliary body to the canal
of Schlemm.
As seen in the Fig. 2-12 the aqueous humor is formed continuously by the
epithelial cells of the ciliary processes in the posterior chamber behind the iris and flows
into the anterior chamber via the pupil. Aqueous fluid circulates in the anterior chamber
by hydrostatic forces, by mechanical means due to ocular and head movements, and by
temperature differential between the vascular iris (warm) and the avascular cornea
(cooler). The hydro-mechanical property of the aqueous humor is largely responsible for
the intraocular pressure and, in conjunction with the fibrous tunics of the eye, provides
the stability of the ocular dimensions and of the internal structures of the eye that is
essential in the performance of the visual function. Finally, most of the aqueous humor
leaves the eye via trabecular meshwork, Schlemm’s canal, the scleral collector channels,
the aqueous veins, and the episcleral venous system.
2.3.2 Posterior Chamber
The aqueous humor is secreted by the ciliary bodies in the posterior chamber,
which is bound anteriorly by the pigment epithelium of the posterior iris; anterolaterally
by the junctional zone of the iris and ciliary body; and anteromedially by the contact of
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the iris with the lens. Aqueous humor gains entry into the anterior chamber from the
posterior chamber via pupil. The equatorial portion of the lens forms the medial boundary
of the posterior chamber. Posteriorly, the anterior face of the vitreous limits it. Laterally,
the chamber is bounded by the ciliary body with its processes and valleys, and it may
extend back to the point of contact between the anterior face of the vitreous.
2.3.3 Vitreous Cavity
The space between the retina, ciliary body, posterior chamber and lens is filled
with a transparent gel (gel vitreous) or a transparent liquid (liquid vitreous) or both. The
vitreous, which occupies almost four-fifth of the volume of the globe, is a clear,
transparent, avascular, gel-like structure of semi-solid consistency. The gel vitreous
portion is a collagen gel in which the water-soluble collagen fibrils are responsible for the
gel state. These fibrils are remarkably uniform in diameter (10-20 µm) throughout the
animal kingdom. These fibrils are heterotypic in composition; comprising collagen types
II, V/XI and IX, though recently even type VI collagen has been identified in the vitreous
[75]. They form an almost completely random network. In mammalian vitreous, the
glycosaminoglycan (GAG) hyaluronan is a major component that fills the space between
the collagen fibrils, but chondroitin sulfate proteoglycans have also been documented
[76]. In many species such as cattle, horses, sheep, dogs, cats, rabbits, etc., the entire
vitreous space is filled with this gel throughout life. Liquid vitreous is present only in
adult eyes of some species (human, rhesus monkey, owl monkey, birds and fishes) and is
always contained within the gel vitreous. The framework of the vitreous body changes
with age. In humans, aging brings important changes in the rheological characteristics
and the nature of the vitreous. From the age of 45-50 years, the volume of the gel-
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vitreous in the human eyes decreases steadily, and the volume of the liquid-vitreous
proportionally increases. This has been observed with slit lamp investigation carried out
by Eisner [46] with direct measurement of the liquid vitreous in formalin-fixed eyes. The
associated shrinkage, contraction, and retraction of the vitreous framework may separate
it from the inner retinal surface.
The vitreous body in the human eye weighs about 4 gm and its volume is
approximately 4 ml; it consists of 99 % water. The specific gravity (1.0053 to 1.0089) is
only slightly higher than that of water, and its refractive index (1.334) is slightly lower
than that of aqueous humor. Its viscosity is almost twice than that of water, but the
osmotic pressure is very close to that of aqueous humor. The vitreous has no blood
vessels and derives its nutrition from the surrounding structures like choroids, ciliary
body and retina. The vitreous is probably never regenerated [74].
The vitreous, with its transparent but solid character, servers as a stabilizer and
shock absorber of any movement or mechanical impact reaching these tissues. The
vitreous, as a solid system with visco-elastic qualities, prevents dislocation of the retina,
lens and zonules. Vitreous is undoubtedly the most delicate connective tissue structure of
the body. Even after fixation, the vitreous body is incapable of maintaining its shape, and
the shape of the vitreous cavity, which is spheroidal posteriorly, determines its outline.
The large volume of the vitreous body provides support for the intraocular structures
including the lens and, in conjunction with the aqueous humor and the fibrous tunics of
the eye, helps to maintain the intraocular pressure. The hyaloid membrane, the lens and
the retina forms the limiting boundary for the vitreous body. The hyaloid membrane is
composed of loosely packed collagen fibers and hyaluronic acid, and spans the gap
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between the lens and the ciliary body. Although the hyaloid membrane forms a boundary
between the nearly stagnant vitreous and the flowing aqueous humor, it does not form a
limiting boundary to the transport of small molecules such as fluorescein. The functions
of the vitreous are as follows:
•

Vitreous humor has a refractive index of 1.33 and thus contributes to the
magnifying power of the eye.

•

It acts as a shock absorber, supporting the shape of the eye and the posterior
surface of the lens.

•

It assists in holding the neural and the pigmented parts of the retina together.

•

It allows the circulation of metabolic solutes and nutrients.

2.4 Lens and Zonular Apparatus
The human lens is a transparent, biconvex, elliptical, semi-solid, avascular
structure with smooth, shiny surfaces. In infants and children, the lens is soft but the
central or nuclear portion becomes firmer with advancing age. The lens is located
between the iris and the vitreous, with its anterior central region exposed by the pupil.

Figure 2-13: Schematic representation of lens
The posterior surface of the pupillary part of the iris glides over the anterior
surface of the lens, Fig. 2-13. In eyes with a narrow anterior chamber angle and shallow
anterior chamber, the iris-lens contact may be wider and firmer causing interference with
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the passage of the aqueous humor from the posterior to the anterior chamber, and may be
a causative factor in angle-closure glaucoma.
Peripherally, the equatorial region of the lens (rounded junction of its anterior and
posterior surfaces) projects into the posterior chamber and is separated from the ciliary
body by a 0.5 mm wide circumlental space. The lens is supported by a system of zonules
(suspensory ligaments) which extend from the ciliary epithelium to a 2.5 mm circular
zone around the lens equator; 1.5 mm of this is on the anterior, and 1 mm on the posterior
lens surface. When traction is applied, during relaxation of the ciliary muscles, the zonule
induces dentate processes on the otherwise smooth, rounded lens equator.
The shape of the human lens in vivo is, to some extent, dependent upon the
tension of the suspensory ligament, which in turn, is dependent upon the tone of the
ciliary muscle and the inherent elasticity of the lens tissue. The shape of the lens in situ,
therefore, differs from that of the excised lens. The lens is almost spherical at birth and
flattens markedly during the first two years of life. In adults, the anterior surface is a
flattened ellipsoid with an average radius of curvature of 10 mm (range, 8 to 14 mm). The
geometric center of this curve constitutes the anterior pole, which is about 3 mm distant
from the central posterior corneal surface (i.e., the depth of the anterior chamber). The
posterior lens surface is curved more steeply, with an average radius of 6mm (range, 4.5
to 7.5mm). At birth, the equatorial diameter is about 6.25 mm and 9 to 10 mm in adult
life. The axial (sagittal) diameter, which joins the anterior and posterior poles, varies
markedly with age and accommodation. The axial diameter is approximately 3.5 to 4 mm
in the newborn and in young children; between the ages of 20 and 50 years, it changes
little; in the extremely old, it gradually increases to almost 5 mm. The weight of the lens
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also increases with age, with an average of 65 mg at birth, 130 mg by the end of the first
year, 204 mg between 40 and 50 years, and 266 mg between 80 and 90 years.
The lens has three main components: the lenticular capsule, the lens epithelium,
and the lens cells or fibers constituting the cortical and nuclear zones.
2.5 Vitrectomy
2.5.1 Current Treatment of Posterior Segment Eye Diseases
Vitreous disease is often treated with any related retinal disease. For example, in
cases of a severe retinal detachment, or growth of abnormal blood vessels into the eye
caused by diabetic retinopathy, it may be necessary to perform a vitrectomy: removal of
the vitreous gel and its replacement with an artificial substitute. Vitrectomy may also be
performed if the vitreous is clouded by blood or scar tissue [46]. Since changes in the
vitreous are the primary cause of retinal detachment, it is clear that ideal techniques to
prevent and repair retinal detachment require that we learn how to prevent the vitreous
gel from liquefying, shrinking, and tearing the retina in the first place. The most prevalent
conditions like diabetic retinopathy and ARMD are usually treated by laser
photocoagulation of the affected areas to destroy the stimulus for new vessel formation,
although it has the disadvantage of causing possible damage to the retina and surrounding
normal areas [52].
Various drugs including steroids, antiproliferative agents, antiviral drugs are used
in the treatment of various infective vitreoretinal conditions. The isolation of vitreous
caused by the blood–retinal and blood–aqueous barriers creates difficulties for effective
drug therapy. Systemic administration is not feasible because only a small percentage of
drugs can penetrate the barriers (e.g., chloramphenicol and tetracycline). Thus, the most
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common method of drug delivery to the eye is topical. However, this is not suitable for
the posterior segment because the drug would need to penetrate the cornea, pass through
the anterior segment against the flow of aqueous humor and diffuse throughout the
vitreous achieving a very low concentration in the vitreous [45].

Figure 2-14: Schematic representation of vitrectomy surgery [73]
Vitreoretinal surgery is employed in later stages of PDR. The treatment of retinal
detachment associated with simple retinal breaks except for giant tears employs either
scleral buckling or pneumatic retinopexy with the purpose of sealing the retina. Less
successful is the repair of tractional retinal detachment, giant tears and other complicated
cases that require vitrectomy and the substitution of vitreous with a more permanent
tamponade agent [74]. Vitrectomy is a microsurgical procedure in which specialized
instruments and techniques are used to repair retinal disorders, many of which were
previously considered inoperable. The initial step in this procedure is usually the removal
of the vitreous gel through very small (~1.4mm) incisions in the eye wall, hence the name
"vitrectomy". The vitreous is removed with a miniature handheld cutting device and
replaced with vitreous substitutes, which is similar to the liquid being removed from the
eye. A high intensity light source is used to illuminate the inside of the eye while the
surgeon works. Although vitrectomy procedures are sometimes performed through
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incisions made near the front of the eye, most vitreoretinal surgeons enter the globe
through a part of the eye known as the pars plana. Entering the eye through this location
avoids damage to the retina and the crystalline lens. This is why the procedure is often
referred to as a trans pars plana vitrectomy (TPPV).
2.5.2 Indications for Vitreous Replacement: Posterior Segment Eye Disorders
The prevalence of blindness in developed countries varies from 0.05 to 0.20%,
while it is many times higher for Asia (0.75%) and Africa (1.0%). Diabetic retinopathy
accounts for 5% to 10% of registered blind in USA and UK while age-related macular
degeneration (ARMD) contributes to nearly 30% of blind [74]. Broadly, the posterior
segment eye disorders may be vitreous or retinal pathologies. However, both are related
as retinal tears can lead to vitreous displacement and vitreous scarring causes retinal
detachment.
2.5.2.1 Vitreous Pathologies
•

Vitreous hemorrhage: This could be due to injury, diabetes mellitus with
retinopathy, hypertension and arteriosclerosis or malignant melanoma of the
choroid.

•

Degeneration and detachment of the vitreous: Degeneration primarily occurs
when the gel structure is disrupted. It may be due to senility, ocular trauma, high
myopia, proliferative diabetic retinopathy or chorioretinitis. The liquefied vitreous
gains access to the retro-hyaloid space, through a hole in the thinner posterior
vitreous cortex and separates the posterior vitreous from the internal limiting
membrane of the retina. This causes the collagen meshwork to collapse and move
forward, a phenomenon known as posterior vitreous detachment (PVD) [74].
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•

Vitreous opacities: These are floating bodies which develop in the vitreous humor
and which may cause transient opacification or disturbances in vision.

2.5.2.2 Retinal Pathologies
•

Retinal detachment: Here, the fragile retina is separated from the underlying
epithelium.

•

Age-related macular degeneration (ARMD): ARMD is a degenerative condition
of the macula. It is the most common cause of vision loss in the United States in
those 50 or older, and its prevalence increases with age. ARMD is caused by
hardening of the arteries that nourish the retina. This deprives the sensitive retinal
tissue of oxygen and nutrients that it needs to function and thrive. As a result, the
central vision deteriorates.

•

Diabetic retinopathy: This is a major cause of blindness in elderly subjects and
develops frequently in longstanding cases of diabetes especially more than 10
years duration [74].

2.5.3 Role of Vitreous Substitutes
The requirements of the vitreous substitutes are as follows:
•

In intra-operative procedures such as unfolding of the retinal tears, the removal of
subretinal fluid and the floatation and removal of dislocated intraocular lens
components.

•

Achieving a relatively short-term tamponade effect such as in pneumatic
retinopexy.

•

As a long term tamponade agent in cases of retinal detachment and in cases of
degenerative changes in the vitreous.
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•

For developing a sustained release system that could maintain therapeutic drug
levels in the posterior segment of the eye over long periods [32].
Materials have been used to replace the vitreous throughout the 20th century and

the search for an ideal vitreous substitute is ongoing. A major division of the current
vitreous substitutes is between those with a short-term tamponade effect as the various
gases and those, which promise to act as a longer-term tamponade with one main factor
determining the permanence of the tamponade effect being interfacial surface energy.
Materials that form an interface with the aqueous environment of the eye can be effective
in closing retinal breaks and holding the neural retina in place against the retinal pigment
epithelium.
2.5.4 Classification of Vitreous Substitutes
The vitreous substitutes may be classified according to composition or function.
•

Classification based on composition
Vitreous substitutes used clinically or experimentally include:
(A) Replacement with natural vitreous
(B) Artificial vitreous substitutes
1. Gases:
(a) Air.
(b) Perfluorocarbon gases.
2. Liquids:
(a) Aqueous solutions: water and balanced salt solutions.
(b) Silicone oil and its derivatives: silicone oil, fluorosilicone oil and siliconefluorosilicone copolymer.
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(c) Perfluorocarbon liquids: Perfluoro-n-octane, perfluorohydrophenanthrene,
perfluorotributylamine, perfluorohexyloctane, perfluoropolyether and others.
(d) Semifluorinated alkanes.
3. Gels: These are mainly polymeric materials and can be further grouped as:
(a) Semisynthetic polymers: methylated collagen, sodium hyaluronidate,
hyaluronic acid collagen mixture, and sodium carboxymethylcellulose.
(b)

Synthetic

polyacrylamide,

polymers:

poly(1-vinyl-2-pyrrolidinone),

poly(glyceryl-methacrylate),

polyvinylalcohol,

poly(2-hydroxyethyl

acrylate),

poly(methyl acrylamidoglycolate methyl ether).
•

Classification based on function
However, perhaps a more convenient way to classify the vitreous substitutes

would be according to role they currently play in the treatment of various vitreoretinal
pathologies as:
1. Short intraoperative procedures: gases and perfluorocarbon liquids.
2. Longer-term retinal tamponade: silicone oil.
3. Permanent vitreous substitute: no material currently available.
4. Sustained intravitreal drug delivery: polymeric hydrogels.
2.5.5 Different Types of Drug Delivery to Posterior Segment of the Eye
Ophthalmic drug delivery is one of the most interesting and challenging
endeavors facing the mechanical community. Drug delivery to the posterior segment of
the eye is not an easy assignment. The anatomy, physiology, and biochemistry of the eye
render this organ exquisitely impervious to foreign substance. It is not uncommon for a
drug to have more than one penetration pathway to move from the administration site to
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the target site. However, typically, not all the penetration pathways are equally important.
The contribution of some pathways may be so small that they are practically non-existent.
In other words, the performance of a model will not be significantly affected even though
some pathways are removed from the model because they are pharmaco-kinetically
unimportant. In order to develop a simple but realistic model, it is essential to have a
clear understanding of the contribution of each penetration pathway.

Figure 2-15: Drug delivery alternatives for treating posterior eye diseases. Topical drops
(a) must diffuse across the tear film, cornea, iris, ciliary body, and vitreous before
reaching the target tissues in the posterior eye, severely diluting the fraction of drug
reaching the retina. Systemic drug delivery (b) also has a poor dose–response profile for
the retina. Intravitreal injection or implant (c) and transscleral diffusion (d) may increase
drug proportions reaching the retina. [32]
Currently, the treatment of retinal diseases is limited by the difficulty in
delivering effective doses of the drugs to target tissues in the vitreous chamber. Many
drugs have a narrow concentration window of effectiveness and may be toxic at higher
concentrations. Therefore the ability to predict local drug concentration is critical for
proper drug delivery. Current methods for ocular delivery include topical administration
(eye drops), subconjunctival injections, periocular injections, intravitreal injections,
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surgical implants, and systemic routes (Fig. 2-15). However, all of these methods have
limitations. Therapeutic levels of many drugs may be difficult to achieve in ocular tissues
and systemic toxicities are of concern when the oral and intravenous routes of
administration are used. Intravitreal injections, periocular injections, and sustainedrelease implants can be used to achieve therapeutic levels of drugs in ocular tissues, but
invasive methods are inherently risky due to the potential for bleeding, infection, retinal
detachment, and other local injuries. A typical ophthalmic dropper delivers 30 µl, most of
which is rapidly lost through naso-lacrimal drainage immediately after dosing. It has been
estimated that typically less than 5% of a topically applied drug penetrates the cornea and
reaches intraocular tissues. Eye drops are useful in treating conditions affecting either the
exterior surface of the eye or tissues in the front of the eye, but cannot penetrate to the
back of the eye for treatment of retinal diseases. The majority of the topically applied
drugs enter the eye by passage across the cornea. This is an extremely inefficient process
owing largely to the resistance exerted by the corneal epithelium to drug penetration. The
corneal epithelium contributes over 90% of the corneal resistance to penetration to the
topically applied drug. A measure of the corneal penetration efficiency of drugs is the
permeability coefficient. This is generally on the order of 0.1-4.0 E5 cm/s.
An intravitreal injection provides the most direct approach to delivering drugs to
the tissues in the vitreous segment, and therapeutic tissue drug levels can be achieved.
Intravitreal injections, however, have potential side effects of retinal detachment,
hemorrhage, endophthalmitis, and cataract. Further, drugs injected directly into the
vitreous are rapidly eliminated. In many cases, repeated injections are needed to maintain
the effective range of drug concentrations for a certain period of time since the half-life
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of drugs in the vitreous is relatively short. Repeated injections cause patient discomfort
and may further lead to complications such as vitreous hemorrhage, infection, and lens or
retinal injury. Therefore, an understanding of the transport of different drugs following
intravitreal injection is necessary, so that, the most effective utilization results from each
injection.
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CHAPTER 3. SIMULATIONS OF OUTFLOW PATHWAY OF
HUMAN EYE
3.1 Geometrical Model of Anterior chamber of Human Eye
Z

Cornea

Y

Anterior
Chamber
Iris

(a)

Lens
Posterior Chamber

(b)

Figure 3-1: (a) Pictorial representation of outflow path of AH in the human eye [78], (b)
Vertical section of the computational grid
In this section, attention is focused only on the anterior segment of the human eye.
The anterior segment of the eye is divided into two parts: 1) The region between the iris
and the cornea, called the anterior chamber and 2) The region between the iris and the
hyaloid, called the posterior chamber. The depth of the anterior chamber of the human
eye is approximately 3 mm [54] and diameter in the plane of the iris root is 11-12 mm
[54]. Therefore, the anterior chamber is modeled as part of a sphere of radius 7.2 mm
[54] and the depth along the central axis is taken to be 3 mm. The anterior chamber is
bounded by the inner surface of the cornea and by the inner surfaces of the trabecular
meshwork. The cornea is modeled as rigid shell with thickness of 0.6 mm, Fig. 3-1(b).
On the posterior side, the anterior surface of the iris and the pupillary portion of the
anterior lens surface bound the anterior chamber. The iris, which is a front extension of
the ciliary body, has a slightly elliptical shape with a vertical axis of 11-12 mm long. It is
perforated by a pupil, which changes its diameter depending on the amount of the light
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falling on the eyeball. The iris is modeled here as a rigid elliptical disc of uniform
thickness of 0.4 mm with a circular papillary hole of radius 2 mm [18] at the center, Fig.
3-1(b). The circular aperture at the center represents the pupil through which flow from
the posterior chamber enters the anterior chamber. The anterior and posterior surfaces of
the iris are modeled as part of spherical surfaces of radius 21.6 mm and 22.1 mm
respectively.
The posterior chamber is bound posteriorly by the hyaloid membrane;
anteromedially by the contact of the iris with the lens; anteriorly by the pigment
epithelium of the posterior iris surface and anterolaterally by the junctional zone of the
iris and ciliary body [54]. The hyaloid membrane is treated as a plane surface bounding
the posterior chamber from the vitreous side. The lens is described as an ellipsoid of 4
mm diameter in the anterior-posterior axis and 9 mm diameter in the two other axes. Its
center is located in such a way that the depth of the anterior chamber is 3mm and only the
anterior surface of the lens needs to be meshed. Under certain conditions, the lens is
subjected to significant movement but in the present study it is assumed to remain
stationary. The temperature of the lens is also assumed to be constant and equal to the
body core temperature. The curved boundary surrounding the posterior chamber is treated
as the ciliary body, which secretes the fluid at constant volume flow rate of 2.5 µL/min.
The AH secreted in the posterior chamber, enters the anterior chamber through the small
gap between the iris and the lens, is estimated to be few microns (10-25 ≈µm) wide [18].
In the present study, the gap between the iris and the lens surface is assumed to be 15 µm.
AH exits the anterior chamber through a drainage system located at the angle formed
where the iris and the cornea meet, where it passes through a sieve-like system of spongy
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tissue called the trabecular meshwork and drains into a channel called Schlemm's canal.
This channel connects to numerous small connector channels buried in the sclera and
forming the intrascleral plexus. From this plexus the blood, containing the aqueous
humour, passes into more superficial vessels; it finally leaves the eye in the anterior
ciliary veins.
Z
Y

UM + CM
JCT
SC

UM + CM
JCT
SC

(b)
(a)

Z

Collector Channel
X

SC

Outer wall of SC

JCT

(c)

UM+
CM
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Figure 3-2: (a) Pictorial representation of Trabecular meshwork [79] and (b) Detailed
computational domain of the Trabecular meshwork (c) Grid distribution in the TM and
SC region and (d) Outer wall of Schlemm’s canal.
The TM is modeled as a porous annular ring located at the root of iris. The AH
pass through the pores of the TM whose characteristics changes in the outflow direction.
The structure of this region is similar to that of a well-designed filter, so a precise
modeling of this region is very important. TM consists of three regions: 1) Uveoscleral
meshwork (UM), positioned immediately next to the anterior chamber, 2) Corneoscleral
meshwork (CM), located next to the uveal meshwork and 3) Juxtacanalicular Tissue
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(JCT), which is widely believed to generate the bulk of aqueous humor outflow resistance
[4]. In the present model, the TM is defined as a two-layered region. The pore size for the
normal UM and CM is large (25-10 µm) and it is believed to offer little resistance. As
this region does not act as the major site of resistance, they are modeled as a single
region. This region is treated as a porous region at the entry of the annular porous zone
with a resistance coefficient corresponding to 10 µm pore size [54]. The CM consists of
50 % collagen fibrils [17] which causes an increase in the resistance. The TM has a
tapering cross-section and its height towards the anterior side (i.e., toward the anterior
chamber) is 640 µm whereas the length is 160 µm [Fig 3-2(b)]. The length of this porous
region over which the pressure changes is defined by a combination of Darcy's Law and
an additional inertial loss term. The JCT is the outermost portion of the TM and the
length of this tissue was found by Ethier et al. [6] to be in the range 8-16 µm. In the
present study, the length of this tissue is assumed to be 10 µm.
In the human eye, the circumference of the SC is about 36mm [17]. The lumen of
SC in human eye varies from 200-400 µm in meridional axis whereas 10-25 µm in
opposite axis [5]. In the present study the dimensions of the SC is considered to be 300
µm in meridional axis and 10 µm in the opposite axis [Fig. 3-2(b)]. The SC is assumed to
be in the form of a single circumferential gutter. AH is drained away from the SC through
numerous collector channels (i.e., 25-35 in number) [17]. In the current study, it is
assumed that there are 30 collector channels evenly spaced around the corneoscleral
limbus, and therefore each collector channel is spaced out at a distance of 1.2 mm [5].
Collector channels are assumed to be of uniform diameter 30 µm [17]. The rate at which
aqueous humor is produced from the ciliary body is 3 µl min-1 in a normal eye of which
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20 % leaves through Uveoscleral outflow and therefore 2.4 µl min-1 exits through the TM.
This 2.4 µl min-1 is drained by these 30-collector channels, each draining 0.08 µl min-1.
The aqueous humor is finally drained out into the aqueous veins, where the venous
pressure is estimated to be close to 9 mm of Hg (1.2 KPa).
Intraocular pressure (IOP) is a measurement of the fluid pressure inside the
anterior chamber of the eye. In the normal eye this pressure is around 2000 Pa whereas in
the diseased condition i.e., glaucoma this pressure can increase up to 8000 Pa [47]. In the
present study, both cases (1) Normal and (2) Glaucomatous Condition are considered. For
the normal eye, different approaches are used to progressively improve and understand
the resistance due to the TM and the IW of SC and finally obtain a 6 mm Hg (or 800 Pa)
pressure drop between the outlet pressure of the venous system (9 mm Hg or 1.2kPa) and
the anterior chamber (average IOP 15 mm Hg or 2000 Pa). Two different approaches are
considered (1) JCT as the main source of resistance and (2) The IW of SC as the main
source of resistance. The following different models are developed for the normal eye:
•

Case 1: JCT as the source of resistance (JCT-R case)
In the simplest case considered, the JCT and the IW of SC are considered to be

coupled together. Using conventional transmission electron microscopy combined with
Carmen-Kozey theory, Ethier et al. [4] found that the pore diameter in the JCT is in the
range of 1-1.5 µm. In the current model, the pore diameter is assumed to be 1.5 µm and
the void fraction in JCT is tailored to obtain the normal eye pressure i.e., 2000 Pa. The
void fraction value is found to be 0.044. For this case, where the JCT is considered to
generate the bulk of aqueous outflow resistance [66], the permeability value was
calculated by Johnson et al. [66] to be in the range 3 e-18 – 6.5 e-17 m2. The permeability
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values obtained by the current model K=2.743e-17 m2, for the present case where JCT is
the main site of resistance, lies in the range of permeability value obtained by Johnson et
al. [66].
Table 3-1: Characteristics of TM for Normal condition
Region
UM + CM
JCT
•

Pore Diameter “d” µm
10
1.5

Void fraction “ε”
0.5
0.044

Permeability K (m2)
8.399e-13
2.743e-17

Case 2 A: IW of the SC as the source of resistance (IW-R case)
The idealized model discussed above can be improved by separating the JCT and

the IW of SC as two distinct regions. The IW of SC is modeled as a porous zone of 1 µm
length. The characteristics of the JCT are obtained from the experimental results of Ethier
et al. [3-4], where using Carmen-Kozeny theory combined with conventional
transmission electron microscope, it was found that the porosity of JCT was
approximately 15-25 % and the diameter of the pore is approximately 1-1.5 µm and
hence the permeability value was calculated to be in the range 2-10 e-11 cm2. The
diameter of pores in the IW is in the range 0.1-3 µm [30] and void fraction is in the range
0.0002-0.02. The values of “d” and “ε” calculated [Table 3-2], lie in the range provided
by Johnson et al. [66].
Table 3-2: Characteristics of TM and IW for Normal condition
Region
UM + CM
JCT
IW of SC
•

Pore Diameter “d” µm
10
1.5
1.5

Void fraction “ε”
0.5
0.25
0.015

Permeability K (m2)
8.399e-13
2.1839e-15
2.14e-18

Case 2 B: IW with distributed pores as the sources of resistance (IWP-R case)
A more accurate and detailed geometrical representation will be to represent the

individual pores located along the IW of SC. Ethier et al. [30] showed that in normal eye
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only 0.2 % area of the IW is open for the AH to drain into aqueous veins. Here in this
case, the IW of SC is modeled as a wall and only 0.2 % of the total area is open. The
characteristics of UM + CM and JCT in the TM are as described in Table 3-2.

n=81
n=20
n=20
Figure 3-3: Schematic representation of IW pore distribution (Note: not all pores are
shown)
Parc et al. [26] showed that the vacuoles are preferentially found near collector
channels, indicating that the aqueous flow across the inner wall is sensitive to
downstream pressure. They also showed that twice as many vacuoles were present in the
region underlying the collector channel ostia as in the region between the channel ostia.
Therefore, in the current model, the IW is divided into two regions. The region
underlying the collector channel has twice the number of pores than the region away from
the collector channel. Each pore is considered to be of square cross-section with the
length of 3µm. As only 0.2 % of the IW area is open, the number of pores in the inner
wall is calculated to be n=121 (approximately). The pores are distributed in such a way
the region underlying the collector channel has n=81 pores and the region away from the
collector channel has n=20 pores.
For Glaucomatous Condition, where the IOP=8000 Pa [47] two approaches were
used to progressively improve and understand the resistance due to the trabecular
meshwork and Inner Wall of Schlemm’s canal and finally get a 51 mm Hg (or 6800 Pa)
pressure drop between the outlet pressure of the venous system (9 mm Hg or 1200 Pa)
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and the anterior chamber (average IOP 60 mm Hg or 8000 Pa).
•

Case 3: JCT as the source of the resistance (JCT-R)
Ethier et al. [4] found that the pore diameter in JCT is in the range1-1.5 µm. In the

current model, the pore diameter is assumed to be 1.0 µm and the void fraction in JCT is
tailored to obtain the eye pressure drop i.e., 6800 Pa.
Table 3-3: Characteristics of TM for Glaucomatous Condition
Region
UM + CM
JCT
•

Pore Diameter “d” µm
10
1.5

Void fraction “ε”
0.5
0.018

Permeability K (m2)
8.399e-13
3.2875e-18

Case 4: IW of the SC as the source of resistance(IW-R)
Here in this case, the IW of SC is modeled as a porous zone of 1 µm length. As

described in IW-R case, the characteristics of JCT are obtained from the experimental
results of Ethier et al. [4].The diameter of pores in the IW is in the range 0.1-3 µm [26]
and the void fraction is in the range 0.0002-0.02. The values of “d” and “ε” calculated
[Table 3-4], lie in the range provided by Johnson et al. [66].
Table 3-4: Characteristics of TM and IW for Glaucomatous Condition
Region
UM + CM
JCT
IW of SC

Pore Diameter “d” µm
10
1.5
1.0

Void fraction “ε”
0.5
0.25
0.007

Permeability K (m2)
8.399e-13
2.1839e-15
1.589e-19

3.2 Numerical Details
3.2.1 Grid Generation
The three-dimensional geometry of the human eye is generated using the
commercial software Grid-Pro. A structured multi-block mesh with 6,541,250 hexahedral
cells of aspect ratio less than two are used in the computational domain. The entire
geometry is divided into 3,922 blocks with 2,250 blocks representing the trabecular
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meshwork and the Schlemm’s canal region. The UM-CM and JCT are modeled as two
different layers with different specific hydraulic permeability. In order to account for the
pores in the IW of SC, which are around 1-3 µm [30], only 12-degree section of the eye
is taken into consideration for computation. In the porous medium region, i.e. the TM
region, the pressure drop appears as a momentum source term, which yields a loss of
diagonal dominance and poor convergence rates. To avoid exacerbating convergence
issues, it is critical to have high quality orthogonal grids with moderate aspect ratios.
Nested topology is used [Fig. 3-2(c)] to obtain large number of cells only in the JCT and
the SC region in order to accommodate the pores of 3µm length in the IW of SC.
3.2.2 Boundary Conditions

Periodic
Boundary

Pressure Outlet
Mass Flow Inlet
(a)

(b)

Figure 3-4: (a) Boundary condition applied to the computational domain and (b) zoomed
view of the encircled region shown in Fig. 3-4(a)
The aqueous humor properties are very similar to those of water and are detailed
in Table 3-5. As the computational domain is symmetrical and the problem of interest
incorporates for the pores in the IW of SC which are around 1-3 µm in diameter,
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therefore to accommodated such a small mesh size, the calculations are carried out for 12
degree section of the eye, [Fig. 3-4(a)]. As shown in Fig. 3-4, periodic boundary
condition is applied to the section ends of the domain.
For the temperature, the iris and the incoming flow through the pupil are specified
to be at the core body temperature (37ºC). The temperature of the cornea is set at constant
value of atmospheric temperature (35ºC). The Boussinesq approximation is used to
account for the buoyancy effects. This results in an extra term in the momentum equation,
as we will see below. To satisfy the aqueous secretion rate of 2.5 µl/min, a mass flow
inlet condition of 4.17e-8 kg/s is applied at the secretion surface of the ciliary body in the
direction normal to the boundary [Fig. 3-4(a)].
A no slip condition is applied on the surfaces of the iris, lens, retina, cornea and
non-secretive ciliary body surface. We should also recall that these parts remain
stationary. Considering the fact that the aqueous outflow is drained radially through the
trabecular meshwork to the collector channels, the no-slip condition is also applied to the
anterior and posterior surfaces of the ring-like trabecular meshwork. As the collector
channels lead the aqueous humor to the venous system, a pressure outlet boundary
condition of 1200 Pa is applied at the outer part of the collector channel. The inclusion of
the TM with its proper dimensions and characteristics in the present simulation, and the
incorporation of a realistic pressure outlet boundary condition, is a distinct improvement
over previously reported efforts [10, 18]. In this way, the model accounts for the normal
venous pressure conditions. Recalling the TM, described by a porous zone, one of the
objectives of the simulation is to determine the characteristics of this region under normal
IOP i.e., 2000 Pa. Most of the diseases associated with the eye are consequence of
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increase in IOP inside the anterior chamber. The elevated IOP is the main risk factor for
glaucoma and this value goes to 8000 Pa in the diseased state [47]. Here the pore size and
the void fraction in the JCT and IW region are tailored to get the required increase in IOP
in the anterior chamber.
3.2.3 Material Properties
The cornea is a vascular and transparent tissue with thermal properties close to
that of water. The AH is assumed to be linear viscous liquid with properties close to those
of water. The properties used in the present simulations are listed in Table 3-5.
Table 3-5: Thermal and physical properties of the components of the human eye
Eye region

Thermal
Density
conductivity (kg/m3)
(W/m K)

Heat
capacity
(J/kg K)

Viscosity
(kg/ m s)

Aqueous Humor
Cornea
Lens
Iris
Ciliary body

0.58
0.58
0.40
0.58
0.58

4200
4200
4200
4200
4200

0.001
-

1000
1000
1000
1000
1000

Volume
expansion
coefficient
(1/K)
0.0003
-

3.2.4 Governing Equations
The complete three-dimensional incompressible Navier-Stokes equations are
considered with the body force terms accounting for the buoyancy effects. The density
appearing in the buoyancy term is assumed to satisfy the Bousinesq’s approximation. The
pressure drop in the trabecular meshwork satisfies Darcy’s assumption. The resulting
non-dimensional forms of the momentum and energy equations are
∂U i
1
∂ 2U i
Gr
∂P
Uj
=
(
) + δ im ( D2 )θ + (δ im − 1)
− Pi
∂X j Re D ∂X j∂X j
Re D
∂X i

where m represents the index of the co-ordinate direction in which gravity is acting,
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(1)

where Pi is the momentum sink term added in the momentum equation for porous zone.
The second term in right hand side of equation (1) (buoyancy term) is included in the
momentum equation only for the co-ordinate direction in which body forces are acting
(gravity forces). The gravity is applied assuming the horizontal upward facing position of
the human eye, i.e. along the pupil axis perpendicular to the iris surface. For the other two

 ∂P 
 as indicated by the
co-ordinate directions this term is replaced by the term  −
X
∂
i 

equation (1).
Energy equation:
Uj

∂θ
1 1
∂ 2θ
=
(
)
∂X j PrD Re D ∂X j∂X j

(2)

Continuity equation:
∂U j

=0

∂X j

(3)

The following non-dimensional variables are used in Eqs. (1)-(3):
X =

T − TC
x
y
z
u
v
w
, Y= , Z=
; U=
, V =
, W =
; θ=
D
D
D
U in
U in
U in
Tin − TC

where Tin is the temperature of aqueous humor at the inlet (37 °C) and TC is the corneal
temperature (35 °C).
To model the porous regions representing the TM, the momentum sink term ∇P in the
equation (1) is represented by the sum of a viscous loss term (the Darcy term) and an
inertial loss term. Thus,
∇P =

µ
ρ
U i + C2 U i U i
α
2

(4)
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which

Pi =

is

added

Re D D 2U i

α

+

in

momentum

equation

in

non-dimensional

form

as

C2
D U i U i . This term is not included in the momentum equation for
2

non-porous fluidic zone. The momentum sink contributes to the pressure gradient in the
porous cell, creating a pressure drop that is proportional to the fluid velocity (or velocity
squared) in the cell. The porous media model incorporates an empirically determined
flow resistance in the porous region. Since the volume blockage that is present physically
is not represented in the model, the velocity inside the porous medium is computed based
on the volumetric flow rate, to ensure continuity of the velocity vectors across the porous
medium interface. In laminar flows through porous media, the pressure drop is typically
proportional to velocity. So, the viscous term (first term) in equation (4) is more
important with respect to the inertial resistive term (second term). Here α is the
permeability and C2 is the inertial resistance factor. To get appropriate values of the
constants α and C2, a semi-empirical correlation, derived from the Ergun equation [53], is
used. These correlations for the permeability and inertial resistance factor are applicable
over a wide range of Reynolds number and for various packing levels, and are given as:

α=

D p2 ε 3
150(1 − ε )

2

C2 =

3.5(1 − ε )
D pε 3

where D p is the mean particle diameter of the packed bed or pore size and ε is the void
fraction. Void fraction is defined as the volume of voids divided by the volume of the
packed bed region. Based on the data in [17] the void fraction of UM and CM was
considered to be 0.5 and D p =15.87 µm. These values of ε and D p lead to a specific
hydraulic permeability of 8.399 E-13 m2 for UM and CM. In the current model for JCT,
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the pore diameter is assumed to be 1.5 µm and the void fraction in JCT is tailored to
obtain the normal eye pressure i.e., 2000 Pa. In JCT-R case for the normal eye, the values
of ε and D p are calculated to be 0.044 and 6.64 µm [Table 3-1] whereas for the IW-R
case this value is calculated to be 0.25 and 3.43 µm [Table 3-2]. For JCT-R case for the
glaucomatous eye, the values of ε and D p are calculated to be 0.018 and 9.03µm [Table
3-3] whereas for the IW-R case this value is calculated to be 0.25 and 3.43 µm [Table34].
3.2.5 Computer Code

The commercial package FLUENT [56], is used to solve the flow and energy
equations associated to this model. This code is based on a control volume approach
where the computational domain is divided into a number of cells, and the governing
equations are discretized into algebraic equations in each cell. The control-volume
approach leads to a discretized set of equations which satisfies the integral conservation
of the mass and the momentum over each control volume. For solving the system of
algebraic equations a Gauss-Siedel scheme is used. Although the Gauss-Siedel scheme
rapidly removes the high frequency errors in the solution, low frequency errors are
reduced at a rate inversely related to the grid size. A W-cycle multi-grid scheme is used
to accelerate the convergence rate by applying corrections to coarser grid levels. The
coupling between velocity and pressure is handled using the SIMPLEC-algorithm [57],
which uses the conservation of mass equation to derive a pressure corrector equation, and
uses a pressure and velocity correction step to yield continuity satisfying velocity fields at
each iteration. The pressure and velocities are then corrected so as to satisfy the
continuity constraint. The discrete values of the variables are stored at the cell-centers,
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but the convection terms in the discretized equation must be interpolated at the cell faces
from the cell-center values. A second order upwind scheme is used for deriving the face
values of different variables in the momentum equation. For the pressure Poisson
equation, a second order accurate discretization scheme is used. As the number of
hexahedral cells is high, it is difficult to solve on a single processor. The entire
computational domain is solved on a parallel platform with 4 processors.
3.3 Results and Discussion
3.3.1 Grid Independence Study

Velocity (mm/s)

8.0E-02
1,250,000
6,541,250

6.0E-02
4.0E-02
2.0E-02
0.0E+00
0

0.2

0.4
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0.8
1
Z*
Figure 3-5: Velocity magnitude along the central axis of the anterior chamber for
1,250,000 and 6,541,250 hexahedral cells.
To demonstrate grid independence, simulations are run with 1,250,000 and
6,541,250 hexahedral cells for the case where JCT is considered to be the main source of
resistance (JCT-R case). Figure 3-5 shows the plot of the velocity magnitude along the
central axis of the anterior chamber. Less than 2 % variation in the magnitude of the
maximum velocity is observed between the 1,250,000 and the 6,541,250 cell calculation.
In order to accommodate the pores of the IW of SC, large number of grid points i.e.
6,541,250 cells were considered for the calculations.
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3.3.2 Pressure, Velocity, Temperature and Shear Stress Contours (Normal Eye)

(K)

(mm/s)

Z
Y

(a)
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(c)
Figure 3-6: Distribution in the anterior segment of human eye (a) Streamlines mapped on
contours of velocity magnitude, (b) Temperature distribution and (c) Contour of static
pressure
Kumar et al. [10] showed that the gravity plays a major role in determining the
flow pattern of AH inside the anterior chamber. In this study, we have assumed the
horizontal upward-facing position of the human eye where the gravity direction is
perpendicular to the iris surface, and the flow field is axi-symmetric. Figure 3-6(a) shows
the streamlines mapped on the contours of velocity distribution in the anterior segment of
the human eye. As seen in the Fig. 3-6(a), the AH is first secreted by the ciliary body. AH
then flows through the posterior chamber slowly converging towards the pupil at a
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velocity of around 1E-3 mm/s. When approaching the small iris-lens gap, velocity
increases up to 0.119 mm/s at the pupil margin. Entering the anterior chamber through
the pupil, the warm AH first rises upwards to the cooler cornea and then the flow
descends along the corneal surface towards the TM due to the effects of gravity. When
reaching the iris root, the aqueous humor either enters the TM or goes along the iris
surface to finally join the fluid entering the chamber. So a re-circulation zone is created
[Fig. 3-6 (a)]. In the anterior chamber, the highest velocity occurs midway along the pupil
axis (70E-3 mm/s). As seen, a small portion of the re-circulating fluid exits through the
TM. The velocity magnitude at the TM entry is approximately 2 E-3 mm/s, which also
corresponds to the velocity of the fluid turning back along the iris surface. It was
observed that flow profile is almost independent of pore size in the TM, but the IOP of
the anterior chamber increases with decreasing the pore size.
Figure 3-6 (b) shows the temperature distribution in the anterior segment of the
human eye. Within the anterior chamber, the temperature contour shows a thermal plume
from a cool temperature (35°C) on the corneal surface to the core body temperature
(37°C) characterizing the iris surface and the lens. This temperature difference is the
main source to drive the AH within the anterior chamber. Temperature gradient seems
uniform throughout the posterior chamber but is higher in the anterior chamber i.e., in the
region between the cornea and the lens surface.
The pressure variations in the anterior and posterior chamber region are
considerably smaller than the pressure drop across the porous TM. The variation in the
pressure of the anterior chamber is less than 0.01 Pa (Fig. 3-6(c)), which indicates that the
anterior chamber pressure is nearly constant. Heys et al. [18] also reported that the
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pressure is essentially uniform inside the anterior chamber; the present model supports
this observation. Along the TM, i.e., from the anterior chamber to the aqueous veins, the
pressure decreases from the normal IOP of 15mm of Hg (~2 Kpa) to 9 mm of Hg (~1.2
Kpa) corresponding to the pressure in the aqueous veins. The quantities like pressure,
velocity and temperature in the anterior chamber do not change with the different
modeling representations of the TM (i.e., JCT-R, IW-R and IWP-R case), and so the rest
of the chapter is mainly concentrated on the distribution of these quantities in TM region.

(mm/s)

(mm/s)

(mm/s)

CC

CC

CC

TM
IW PORES
SC
SC
(a)
(b)
(c)
SC
Figure 3-7: Streamlines mapped on contours of velocity magnitude (a) JCT-R case and
(b) IW-R case and (c) IWP-R case
TM

TM

The velocity of the aqueous humor decreases when it enters the JCT, where the
pore size is low. In order to achieve a better understanding of the outflow of the AH from
the TM to collector channels, the results are plotted in the vicinity of the pores. Fig. 3-7
shows the streamlines mapped on the contours of velocity distribution in the vicinity of
JCT and SC. In the idealized case where JCT is modeled as a main source of resistance
(i.e., JCT-R case), the IW effects are neglected [i.e., effects of IW pores are not
considered]. In this case, as the pore size in JCT is small (d=1.5 µm and ε=0.044), the
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AH velocity decreases to 2.8 E-3 mm/s while passing through JCT. It is seen that the
velocity decreases as the AH passes through the porous medium but it gains the velocity
when it reaches the non-porous region [i.e., SC] and then exits out through the collector
channel. It is seen that in Fig. 3-7(a), the aqueous velocity increases to a maximum value
of 0.216 mm/s near the collector channel. Figure 3-7(b) shows the velocity distribution
for the case where IW is modeled as a porous medium (i.e., IW-R case). The velocity
distribution pattern is comparable to the case where JCT is modeled as a porous medium.
In the case where 0.2% of area of IW is open (i.e., IWP-R case), flow through the JCT is
confined to the region near the IW pores, forcing a funneling pattern of aqueous
streamlines, as illustrated in Fig. 3-7(c). To enter the SC, AH must converge to pass
through discrete openings along the IW of SC, which decreases the available area for
flow and increases the outflow resistance. Darryl et al. [16] showed that the separation of
the IW of SC from the JCT eliminates the funneling pattern. This is because of the
increases in the available area for flow and the subsequent increase in the outflow facility
during washout [Fig. 3-7(a)], where the effects of IW are neglected. The maximum
velocity in the eye is found in the vicinity of these pores. It is seen that due to the effects
of funneling of the AH, the velocity increases to a maximum value of 0.42 mm/s in the
vicinity of pores.
Figure 3-8 shows that velocity distribution along the axial length of the TM and
SC passing through the IW pore and the center of the collector channel. Here Y* is
defined as the Y-distance/total length of TM and SC [i.e., distance between points A and
B in Fig. 3-8(b)]. It is seen that in Fig. 3-8(a), that the AH velocity is constant as it passes
through the JCT. In the JCT-R case, the AH velocity increases by 25.3 % as it approaches
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Figure 3-8: (a) Line plot of velocity magnitude in axial direction passing through the
collector channel and (b) diagrammatic representation of total length of TM and SC
the collector channel. In the IWP-R case, the velocity of aqueous increases as it passes
through the pores and reaches to a maximum value of 0.42 mm/s. The velocity around the
pore increases by an order of 102 compared to the aqueous velocity in the JCT. It is seen
that the AH exits with a very high velocity through the IW pores and enters the SC.
Hence the velocity of AH is very high in the vicinity of the IW pores while throughout
the remainder of the JCT, the fluid velocities are small.
Figure 3-9 shows the velocity distribution around the pores located in the IW of
SC, which are near and away from the collector channel. It is seen that the aqueous
velocity is high only in the vicinity of IW pores. It is also seen that the velocity of AH is
higher in the SC region near the collector channel compared to the region away from the
collector channel. Figure 3-9 shows the line plot of the velocity in the vicinity of the IW
pores in the axial direction. Here X axis is non-dimensionalized with respect to the
distance between two pores [Fig. 3-9(d)]. It is seen that the AH velocity funneling out of
the IW pores is higher (i.e., approx. 40%) in the region underlying the collector channel
than in the region away from it.

73

Y

(mm/s)

X

(mm/s)

(a)

(b)

Velocity (mm/s)

5.0E-01
Away from CC
Near CC

4.0E-01

B

A

3.0E-01
2.0E-01
1.0E-01

Pore

0.0E+00
(c)

0.4

0.45

0.5
X*

0.55

0.6

(d)

Figure 3-9: Velocity contour in the vicinity of pore (a) Near collector channel, (b) Away
from collector channel, (c) Line plot for the velocity magnitude near and away from
collector channel (i.e., between point A and B) and (d) diagrammatic representation of
distance between two pores
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Figure 3-10: Contour of static Pressure in the TM region
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The variation in the pressure of the TM is shown in the Fig. 3-10. As seen, the
major pressure drop is located in the TM, hence in order to keep figures as clear as
possible, pressure contours are plotted separately for the TM from the rest of the eye [Fig.
3-10]. It is seen that the pressure of the AH decreases when it enters the porous JCT, i.e.,
where the pore size is low. In order to achieve a better understanding of the pressure
distribution from JCT to collector channel, the results are plotted along the line passing
through the pore and center of the collector channel [Fig 3.8(b)].
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Figure 3-11: (a) Line plot of the pressure drop in the JCT and SC and (b) diagrammatic
representation of total length of JCT and SC
Figure 3-11 shows the pressure distribution in JCT and SC region passing through
the pore and center of the collector channel. Here, Y* is defined as the y-distance/total
distance of JCT and SC [Fig. 3-11(b)]. It is seen that the entire pressure drop occurs in
the JCT and the IW region. The comparison of the pressure drop can be readily analyzed
by overlapping the pressure drop for all the three cases. It is seen that the pressure
variation occurs only in the JCT region whereas the SC is at the venous pressure (i.e., at
normal IOP). In the JCT-R case, where JCT is modeled as a porous medium, pressure
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decreases linearly (approximately) from normal IOP to venous pressure. In the IW-R case
where IW of SC is modeled as a porous medium, as the pore size in the IW is small
(d=1.5 µm and ε=0.015), the entire pressure drop occurs in the IW of SC region. In the
IWP-R case where pores of IW of SC act as a main source of resistance, it is seen that the
entire pressure drop (i.e., the 800 Pa pressure drop) occur in the vicinity of the IW pores.
Figure 3-12 shows the contours of the pressure distribution along the
circumferential length of the TM and the SC for all the three cases (at Z=0.0371). As the
pressure plots are symmetrical, Fig. 3-12(a-c) are plotted only for the half section i.e.,
between X=-0.00063 and X=0. It is seen that the TM is at a higher pressure compared to
the SC. It is seen that the highest pressure in the canal is at the midpoint between the two
collector channels i.e., in the region away from the collector channel. The pressure falls
near the collector channel which implies that the IW of SC will experience more pressure
difference towards the collectors and the canal should show a greater tendency to
collapse near and at the collector channel exits. Figure 3-12(d) shows the pressure drop in
the vicinity of IW pores. Figure 3-12(e) shows the line-plot of the pressure distribution
along the circumferential length of SC for all the three cases. In the JCT-R and IW-R
case, it is seen that there is around 0.066% increase in pressure in the region away from
the collector channel compared to the venous pressure. In the IWP-R case, where only
0.2% of IW is open, the pressure increase is only 0.043%.
Figure 3-13(a) shows the pressure distribution in the IW of SC for the IWP-R
case. It is seen that the entire pressure drop occurs in the IW of SC pores. The pressure on
the IW region away from the pore is very high and is approximately equal to the IOP
[Fig. 3-13(a) ]. In order to accomplish a better understanding of the pressure in the
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Figure 3-12: Pressure contour along the horizontal cross-section of the TM and SC (a)
JCT-R case, (b) IW-R case, (c) IWP-R case, (d) zoomed view of the encircled region
around the pore shown in Fig. 3-12(c) and (e) Pressure line-plot along the center-line of
the circumferential length of SC
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Figure 3-13: Pressure distribution on the Inner wall of SC in the vicinity of pores and (a)
Contour plot towards the JCT, (b) Contour plot towards the SC side, (c) Line plot in the
axial direction and (d) zoomed view of the encircled region shown in Fig. 3-13(c)
vicinity of pores, the results are plotted along the line passing through the pore. Figure 313(c) shows the pressure line plot in the vicinity of pores in the axial direction. Here X
axis is non-dimensionalized with respect to the distance between two pores [Fig. 3-9(d)].
For the idealized case, where JCT is modeled as a porous medium i.e., JCT-R case, the
IW is at a constant pressure P=1256 Pa i.e., approximately venous pressure. In the IWP-R
case, it is seen that the pressure decreases from IOP to a value of P=1423 Pa in the IW
pores i.e., the entire pressure drop occurs in the 3µm pore region.
Figure 3-14 shows the contours of the pressure distribution along the
circumferential length of the outer wall of SC. It is seen that the pressure is lower in the
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Figure 3-14: Pressure contour on the outer wall of Schlemm’s canal (a) JCT-R case, (b)
IW-R case, (c) IWP-R case and (d) Pressure line-plot along the center-line of the
circumferential length of SC (e) diagrammatic representation of outer wall of SC along
which Fig. 3-14(d) is drawn
region near the collector channel and it increases gradually away from the collector
channel. The maximum pressure on the outer wall is in the region between the two
collector channels. This decrease in pressure near the collector channel is due to the
increase in the velocity of the AH flowing into the collector channel. Figure 3-14(d)
shows the line-plot of the pressure distribution along the circumferential length of outer
wall of SC for all the three cases [Fig. 3-14(e)]. In the JCT-R and the IW-R case, it is
seen that there is approximately 0.066% increase in pressure in the region away from the
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collector channel compared to the venous pressure whereas in the IWP-R case, the
pressure increase is only 0.043%.
(Pa)
Iris Surface
Lens Surface

Figure 3-15: Wall shear stress contour on the surface of the lens and on the anterior
surface of iris
Figure 3-15 shows the shear stress distribution on the anterior surface of the iris
and on the surface of lens. Significant shear stresses are located in very specific areas of
anterior chamber: 1) At the pupil margin on both the lens and iris surfaces and 2) On the
iris surface at the trabecular meshwork entrance. However, the order of magnitude of the
shear stress is different depending on the location. The shear stress reaches to a maximum
value of 1.38 E-2 Pa at the pupil margin on the lens surface, where the AH enters the
anterior chamber through a very shallow gap lens-iris [i.e., high velocity magnitude
region Fig. 3-6(a)]. The shear stress of the order of 3.49 E-3 Pa is found near the
trabecular meshwork entrance or iris root [Fig. 3-15]. This increase in shear stress at the
iris root may be a factor explaining the liberation of pigments or depletion of proteins
from this surface of iris. These particles could then further obstruct the trabecular
meshwork [9].
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Figure 3-16: Shear Stress on the Inner wall of Schlemm’s canal (a) JCT-R case (b) IW-R
case, (c) IWP-R case and (d) Line plot of shear stress
Figure 3-16 shows the shear stress distribution on the IW of SC. It is seen that the
region underlying the collector channel ostia has higher shear stress compared to the
region away from the collector channel. This implies that the inner wall will experience
more shear stress near the collector channel and that the canal should show a greater
tendency to collapse near the collector channel. For the JCT-R case, the shear stress
reaches to a maximum value of 0.0037 Pa near the collector channel. This increase in
shear stress value in the collector channel ostia may be a factor explaining the higher
number of pores in this region. Parc et al. [26] showed that the region underlying the
collector channel has double the number of pores in the inner wall; the present model
supports this observation. Figure 3-16(b) shows the shear stress distribution for the IW-R
case where IW is modeled as a porous medium. The stress distribution trend in this case
is comparable to the case where JCT is modeled as a porous medium. Figure 3-16(c)
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shows the contour of shear stress distribution for the IWP-R case on the IW of SC. It is
seen that the shear stress is high only in the vicinity of the IW pores whereas the shear
stress is uniformly low in the region away from the pores. Figure 3-16(d) shows the shear
stress line plot on the IW of SC in the axial direction (i.e., X=0.000482 to 0.00065). Here
X axis is non-dimensionalized with respect to the distance between four pores. In the
JCT-R and IW-R case, the shear stress increases to a value of 0.023 Pa whereas in the
IWP-R case, it is seen that the shear stress reaches to a maximum value of 0.49 Pa in the
vicinity of the IW pores. While comparing the results of JCT-R and IWP-R case, the
value of maximum shear stress increases by 20 times in the later case. When compared to
the shear stress value at the iris-lens gap, the shear stress value in the vicinity of pore
increases by 96%.
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Figure 3-17: Shear stress contour on the outer wall of Schlemm’s canal (a) JCT-R case,
(b) IW-R case, (c) IWP-R case and (d) Shear stress line-plot along the center-line of the
circumferential length of SC

82

Figure 3-17 shows the shear stress distribution on the surface of outer wall of
Schlemm’s canal. It is seen that the shear stress is higher in the region near the collector
channel and decreases gradually away from the collector channel. This increase in shear
stress is due to increase in the velocity of the AH gushing into the collector channel, as
shear stress is directly proportional to velocity gradient. Figure 3-17(d) shows the line
plot of shear stress distribution along the mid-plane [Fig. 3-14 (e)]. In JCT-R case, the
shear stress value reaches to a maximum value of 0.067 Pa in the vicinity of collector
channel. In the IWP-R case (i.e., for the case where 0.2% of IW of SC is open), 13 %
higher shear stress is observed compared to the other two cases. The increase in the shear
stress is due to the high velocity of AH gushing out of the pores of the IW.
3.3.3 Pressure, Velocity and Shear Stress (Glaucomatous Eye)

Most of the diseases associated with the eye are consequence of increase in IOP
inside the anterior chamber. The blockage of the eye-drainage system raises the IOP to
abnormal values, which leads to glaucoma. For Glaucomatous condition, where the
IOP=8000 Pa [47] two approaches were used to progressively improve and understand
the resistance due to the trabecular meshwork and IW of SC and finally obtain a 51 mm
Hg (or 6800 Pa) pressure drop between the outlet pressure of the venous system (9 mm
Hg or 1200 Pa) and the anterior chamber (average IOP 60 mm Hg or 8000 Pa).
Figure 3-18 shows that velocity distribution along the length of the TM and SC
passing through the IW pore and the center of the collector channel. Here Y* is defined
as the Y-distance/total length of TM and SC [i.e., distance between points A and B in Fig.
3-8(b)]. It is seen in Fig. 3-18(b) that the velocity of AH increases in the TM for the
glaucomatous eye compared to the normal eye condition.
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Figure 3-18: (a) Line plot of velocity magnitude in axial direction passing through the
collector channel and (b) zoomed view of the encircled region shown in Fig. 3-18(a)

(Pa)
Z
Y
(Pa)

PRESSURE (Pa)

(a)

(b)

JCT-R (IOP=2000 Pa)
IW-R (IOP=2000 Pa)
JCT-R (IOP=8000 Pa)
IW-R (IOP=8000 Pa)

7000
5000
3000
1000
(c)

0

0.5
Y*

1

Figure 3-19: (a) Contour of static pressure (a) Anterior chamber, (b) zoomed view of the
encircled region shown in Fig. 3-19(a) and (c) Line plot of the pressure drop in the JCT
and SC
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The variation in the pressure for the glaucomatous eyes is shown in the Fig. 319(a-b). The pressure variations in the anterior and posterior chamber region are
considerably smaller than the pressure drop across the porous TM. The pressure is
essentially uniform inside the anterior chamber. Along the TM, from the anterior
chamber to the aqueous veins, the pressure decreases from the normal IOP of 60mm of
Hg (~8 Kpa) inside the anterior chamber to 9 mm of Hg (~1.2 Kpa) corresponding to the
pressure in the aqueous veins. Figure 3-19(c) shows the line-plot of the pressure
distribution in JCT and SC region passing through the pore and center of the collector
channel. Here, Y* is defined as the y-distance/total distance of JCT and SC center [Fig.
3-11(b)]. It is seen that the entire pressure drop occurs in the JCT and IW region. The
comparison of the pressure drop can be readily analyzed by overlapping the pressure drop
for the two cases along with the normal IOP case. It is seen that the pressure variation
occurs only in the JCT region whereas the SC is at the venous pressure. For the case,
where JCT is modeled as a porous medium, pressure decreases linearly (approximately)
from high IOP (i.e., 8000 Pa) to venous pressure. In the IW-R case, where IW of SC is
modeled as a porous medium, as the pore size in the IW is small (d=1.0 µm and ε=0.007),
the entire pressure drop occurs in the IW of SC region.
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Figure 3-20: Shear Stress on the Inner wall of Schlemm’s canal (a) JCT-R case (b) IW-R
case
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Figure 3-20 shows the shear stress distribution on the surface of IW of SC for
both the cases. The shear stress trend for glaucomatous condition is comparable to the
normal eye. It is seen that the region underlying the collector channel ostia has higher
shear stress compared to the region away from the collector channel. The shear stress
value is smallest between the two collector channels. In the glaucomatous condition the
shear stress reaches to a maximum value of 0.0052 Pa near the collector channel and this
increase in the shear stress value near the collector channel ostia may be a factor
explaining the higher number of pores in this region. As seen in this case, for
glaucomatous condition there is 40% increase in the maximum value of the shear stress
compared to normal eye condition.
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Figure 3-21: Shear stress contour on the outer wall of Schlemm’s canal (a) JCT-R case,
(b) IW-R case and (c) Shear stress line-plot along the center-line of the circumferential
length of SC

86

Figure 3-21 shows the shear stress distribution on the surface of outer wall of SC.
It is seen that the shear stress is higher in the region near the collector channel and
decreases gradually away from the collector channel. The shear stress value is smallest
between the two collector channels. Here in this case the shear stress reaches to a
maximum value of 0.105 Pa near the collector channel. This increase in shear stress is
due to the increase in the velocity of the aqueous humor flowing into the collector
channel. There is approximately 97% of increase in shear stress magnitude near the
collector channel than in the region away from the collector channel.
3.4 Concluding Remarks

A complete three-dimensional model is developed and a model of the complex
TM is proposed. The TM is represented as a multi-layered porous zone of specified pore
sizes and void fraction for the UM, the CM and the JCT layer. In this study, the following
cases are presented: (1) JCT as the source of resistance (JCT-R), (2) IW as the source of
resistance (IW-R) and (3) IW with distributed pores as the source of resistance (IWP-R).
The IOP predicted inside the anterior chamber and the pressure drop across the TM
(corresponding to real pore size of the JCT) are found to be close to experimental
observations for a normal eye. The following major observations are made from the
computed results.
(1) The hydraulic permeability of porous structures, i.e., TM and IW is calculated and is
reported in Table 3-1 to 3-4.
(2) Predictions verify the dominance of the buoyancy as the driving mechanism for the
AH flow. The temperature difference between cornea and core body temperature is the
main source to drive the AH within the anterior chamber.
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(3) The pressure drop mostly occurs across the JCT and IW of SC. Within the anterior
chamber, the variations in pressure are relatively small.
(4) It was observed that flow profile is almost independent of pore size in the TM, but the
IOP of the anterior chamber increases with decreasing the pore size.
(5) The highest pressure in the canal is at the midpoint between the two collector
channels and the pressure falls near the collector channel. This implies that the IW will
experience more pressure difference towards the collectors, and that the canal should
show a greater tendency to collapse near and at the collector channel exits.
(6) The pores of the inner wall are found to cause a “funneling effect” in which the AH
flows preferentially through those regions of the JCT nearest the inner wall pores.
(7) It is seen that the velocity of AH is higher in the SC near the collector channel than in
the region away from the collector channel. It is seen that there is approximately 40%
increase in velocity of AH near the collector channel.
(8) It is seen that the region underlying the collector channel ostia has higher shear stress
compared to the region away from the collector channel. The shear stress value is
smallest between the two collector channels. There is approximately 97% of increase in
shear stress near the collector channel than in the region away from the collector channel.
(9) While comparing the results of the IWR-P (i.e., where 0.2% area of IW is open), with
the JCT-R case, the value of maximum shear stress increases by 20 times.
(10) For the glaucomatous eye, there is 40% increase in the maximum value of the shear
stress on the IW of SC compared to normal eye.
In future, the model will be extended to account the elasticity of the IW of SC, to
demonstrate the collapse of this canal in the case of high pressure condition. Further the
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model can be developed to study the interactions of ocular particles trapped in the TM
and formations of some structures associated with specific eye disease. These issues have
been ignored in the present study.
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CHAPTER 4. DRUG DELIVERY IN VITREOUS SUBSTITUTES
4.1 Mathematical Model
4.1.1Geometrical Model of Posterior Segment of Human Eye

Hyaloid Membrane
Lens
Drug Injection site
Vitreous Body
Retina
Sclera

(a)

(b)

(c)
Figure 4-1: (a) Cross-section of the human eye, (b) Computational grid and (c) 3-D view
of the grid
The geometrical model adopted in the present study, shown in Fig. 4-1 (b), is
based on the physiological dimensions of a human eye provided by L’Huillier et al. [19].
The vitreous chamber is mainly composed of vitreous humor and comprises about twothird of the eye with a volume of approximately 4 mL [47]. The viscous properties of the
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vitreous humor allow the eye to return to its normal shape if compressed. The crystalline
lens is located just behind the iris and is modeled here as a stationary ellipsoid of 4 mm
diameter along the anterior-posterior axis and 9 mm diameter along the two other axes.
The hyaloid membrane is composed of loosely packed collagen fibers and hyaluronic
acid, and spans the gap between the lens and the ciliary body. Although the hyaloid
membrane forms a boundary between the nearly stagnant vitreous and the flowing
aqueous humor, it does not form a limiting boundary to the transport of small molecules
such as fluorescein. The retina is a light-sensitive layer at the back of the eye that covers
about 65 percent of its interior surface and is immediately adjacent to the vitreous. The
retina is a remarkably fragile tissue, having a thickness of 250 µm [48] and is modeled
here as a sphere with a radius of 9.1 mm. The distance between the lens and retina centre
is 5 mm. The choroid lies between the retina and the sclera. It is composed of layers of
blood vessels that nourish the back of the eye. The sclera is commonly known as "the
white of the eye." It is the tough, opaque tissue that serves as the eye's protective outer
coat. The average thickness of sclera is assumed to be 0.065 cm [47].
4.1.2 Drug Delivery Model

The traditional approach of drug delivery is the direct injection of the drug in a
solution form. More recently, micro-spheres of biodegradable polymer such as poly
(lactic acid) have been used as drug carriers. The micro-spheres of poly (lactic acid) are
resolved into monomers of lactic acid by hydrolytic deesterification before they finally
disappear. In this study, we have explored both these approaches of drug delivery, i.e., (i)
direct injection where the injected drug is instantaneously released from a specified
volume and (ii) Time-released drug injection where the drug is released as a function of
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time. There are many parameters that potentially control how the drug is initially
distributed in the vitreous chamber which include: needle gauge, needle length,
penetration angle of the needle, speed of the injection, rheology of the injected solution,
and rheology of the vitreous. Numerical analysis carried out by Friedrich et al. [36-37]
showed that the results obtained by modeling the initial drug injection site as a cylinder
or a sphere were identical. Therefore, in the present study we have assumed that the drug
is released at the center of the vitreous chamber and that the injected drug initially has a
homogenous distribution within a cylindrical region after injection. The initial size of the
cylindrical region was assumed to be 0.075 cm in diameter and 0.15 cm in height [38].
The density of the drug is assumed to be same as that of water i.e., 1000 Kg/m3. The
initial normalized mass fraction of the drug is assumed to be 1 (normalized with respect
to the concentration of the drug in the water base) within the domain of the drug injection
site while it is 0 in rest of the vitreous.
The diffusivity of small molecules, such as gentamicin, fluorescein and
fluorescein glucuronide in the vitreous humor was found experimentally by Araie et al.
[34] and Kaiser et al. [64] to be 6 E-10 m2/s, whereas for larger molecule drugs, FITC
Dextran, the diffusivity is found to be 3.9 E-11m2/s [77] and moreover for very large
molecules e.g., an antibody, the diffusivity is lower and is of the order of 1 E-11 m2/s
[33]. Therefore, for the current study we have considered three possible diffusion
coefficients for the drugs, i.e., 6 E-10 m2/s, 3.9 E-11 m2/s and 1 E-11 m2/s are considered.
There is no published data that provides the diffusion coefficient of drug in vitreous
substitutes. Rashidnia et al. [50] using interferometric measurements and the Wiener
model calculated the diffusion coefficient of silicone oil with different kinematic
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viscosities. They found out that the diffusion coefficient of 1 cSt oil (viscosity
comparable to water) in 1000 cSt Silicone oil to be 2.48 E-10 m2/s. In the absence of
quantitative information about the diffusion coefficient of drug with silicone oil, a range
of values are chosen, we have considered five possible diffusion coefficients for the drugs
(i.e., 6 E-10 m2/s, 3.9 E-11 m2/s and 1 E-11 m2/s, 6 E-12 m2/s and 1 E-12 m2/s), so that
the results can be used to evaluate the role of the diffusion coefficients within an order of
magnitude variation (from E-10 to E-12).
For Time-released injection, since we are interested in controlling the drug
delivery release rate, we have modeled the source term in the scalar concentration with
the following volumetric release rate of the drug,

q=

M *k
V* t

(1)

where M is the initial loading of the drug (Kg), k is the rate constant of the release (s-1)
and V is the volume of the drug injection (m3). The source term above is defined only at
the injection site and is zero for all other positions within the vitreous. In earlier studies
by Falk et al. [51], who studied the release of gentamicin from poly-(L-lactic) microspheres in cadaveric bovine vitreous, the value of k was taken to be 0.057 day1/2 and the
initial mass of the drug M was assumed to be 795 µg .
4.2 Numerical Details
4.2.1 Grid Generation

The three-dimensional geometry of the human eye is generated using the
commercial software Grid-Pro. A structured multi-block mesh with 541,250 hexahedral
cells of aspect ratio less than three are used in the computational domain. The entire
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geometry is divided into 922 blocks with 5 blocks representing the drug injection
position. The retina and the choroid-sclera are modeled as two different layers with
different hydraulic conductivity. As described earlier, the drug is released at the center of
the vitreous chamber and is assumed be cylindrical in shape at t=0. The drug injection
position is shown encircled in Fig. 4-1(b). As the drug injection site is very small the grid
is refined in the drug injection region.
4.2.2 Boundary Conditions

The hyaloid membrane separates the vitreous humor from the aqueous humor and
the anterior segment of the eye. Therefore, we have considered pressure at the hyaloid
membrane to be same as that of aqueous humor, which is close to the intraocular pressure
of the eye. Normal IOP ranges between 15-20 mmHg (~2000-2666 Pa) but can be nearly
double this value when malignant glaucoma occurs. In the present study, we have
assumed the pressure at the hyaloid membrane to be 2000 Pa. As in Refs. [33, 38], the
concentration is set to zero i.e., C=0 at the hyaloid membrane. This boundary condition is
based on the assumption that the aqueous flow rate is high relative to the release of the
drug. The lens is assumed to be impermeable to both flow and the drug concentration.
Therefore, at the surface of the lens a no-flux boundary condition is applied. The retina
and the sclera are treated as two different layers and each layer is treated as a porous zone
with their respective permeability. In the present work, permeability values from the
literature are used for the retina and the sclera. Drugs with small molecule have higher
retinal permeability, whereas the drugs with large molecules have lower retinal
permeability. It is shown by Friedrich et al. [36] that retinal permeability plays a very
important role in drug distribution. For retina, i.e., for small molecule drugs where D=6
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E-10 m2/s the retinal permeability values reported by Araie [34] 2.33 E-5 cm/s is used
and moreover for large molecule drugs where D=3.9 E-11 m2/s the retinal permeability
value reported by Pitkänen [77] 1 E-8 cm/s is used. For the sclera, which is a dense
connective tissue, Ethier et al. [47] reported a permeability value of 1.96 E-9 cm/s and the
pressure along this surface is assumed to be the normal venous pressure i.e. 1200 Pa. The
choroid layer, which is situated outside the retina, is highly vascularized; therefore, a
reasonable assumption is that choroid will act as a perfect sink for drug transport across
the retina. Therefore, at the outer surface of the retina the drug concentration is set to zero
i.e., C=0 [36, 37].
4.2.3 Material Properties

The most widely used vitreous substitutes is silicone oil [61]. Silicone oil has low
density compared to water, which causes it to float upon the residual fluid and thus helps
in retinal tamponade in the case of superior breaks. Table 4-1 shows the material
properties of silicone oil and water. As seen in Table 4-1, silicone oil has higher viscosity
compared to water (approx. 3 orders higher in magnitude).
Table 4-1: Material Properties of the Vitreous substitutes
Density (Kg/m3)
1000
970

Vitreous Substitute
Water
Silicone Oil

Viscosity (Kg/ms)
0.001
1.067

4.2.4 Governing Equations

The complete three-dimensional incompressible Navier-Stokes equations along
with species transport equation are solved to obtain the velocity, pressure and
concentration fields.
Continuity Equations:

→
∂ρ
+ ∇.( ρ v ) = 0
∂t

(2)
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→

→ →
∂v → →
1
µ
+ ( v .∇) v = − ∇P + ∇ 2 v + g
Momentum Equations:
∂t
ρ
ρ

Species Transport Equation:

∂c →
+ v .∇c − D∇ 2 c − q = 0
∂t

(3)

(4)

where P is the pressure, c is the concentration of the drug, D is the diffusion coefficient
and q is the release rate as a function of position and time. The source term q is modeled
using equation (1).
Porous media is modeled by the addition of a momentum source term to the standard
fluid flow equations. The source term is composed of two parts: a viscous loss term and
an inertial loss term. To model the porous region of the retina and the sclera, the ∇P term
in the momentum

∇P =

equation (2) is represented by the following equation

µ
ρ
Vi + C2 Vi Vi
α
2

(5)

where α is the permeability and C 2 is the inertial resistance factor. To get appropriate
values of constant α and C 2 , a semi-empirical correlation, derived from the Ergun
equation [53], is used. These correlations for the permeability α and inertial resistance
factor C 2 are applicable over a wide range of Reynolds number and for various packing
levels, and are given as:

α=

D p2 ε 3
150(1 − ε )

2

C2 =

3.5(1 − ε )
D pε 3

(6)

where D p is the mean particle diameter of the packed bed and ε is the void fraction.
Void fraction is defined as the volume of voids divided by the volume of the packed bed
region. The sclera consists of 89.7% of water and 7.75% of collagen and
glycosaminoglycans (GAG’s) [49], which causes an increase in the resistance. Based on
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the data in [58] the void fraction for sclera was considered to be 0.91 and D p =1.35 nm.
These values of ε and D p lead to specific hydraulic permeability of 2 E-18 m2 for sclera
which is consistent with those reported by Ethier et al. [47] for the sclera. For the retina,
i.e., for small molecule drugs where D=6 E-10 m2/s the retinal hydraulic conductivity is
2.6 E-5 cm/s [34] and for large molecule drugs where D=3.9 E-11 m2/s the retinal
hydraulic conductivity is 1 E-8 cm/s [77] is used. The void fraction of retina is taken to
be ε =0.6 as provided in [54]. Using Equation (6), for small molecule drugs, D p is
calculated to be 1.71 E-6 m and for large molecule drugs D p is calculated to be 3.36 E-8
m. These values lead to a specific hydraulic permeability value of 2.65 E-14 m2 and
1.019 E-17 m2 respectively.
4.2.5 Computer Code

The commercial code FLUENT [56] is used in this study. This code is based on a
control volume approach where the computational domain is divided into a number of
cells, and the governing equations are discretized into algebraic equations in each cell.
The control-volume approach leads to a discretized set of equations which satisfies the
integral conservation of the mass and the momentum over each control volume. For
solving the system of algebraic equations a Gauss-Siedel scheme is used. Although the
Gauss-Siedel scheme rapidly removes the high frequency errors in the solution, low
frequency errors are reduced at a rate inversely related to the grid size. A W-cycle multigrid scheme is used to accelerate the convergence rate by applying corrections to coarser
grid levels. The coupling between velocity and pressure is handled using the SIMPLECalgorithm [57], which uses the conservation of mass equation to derive a pressure
corrector equation, and uses a pressure and velocity correction step to yield continuity
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satisfying velocity fields at each iteration. The pressure and velocities are then corrected
so as to satisfy the continuity constraint. The discrete values of the variables are stored at
the cell-centers, but the convection terms in the discretized equation must be interpolated
at the cell faces from the cell-center values. A second order upwind scheme is used for
deriving the face values of different variables in the momentum equation. For the
pressure Poisson equation, a second order accurate discretization scheme is used.
4.3 Results and Discussion
4.3.1 Grid Independence Study and Validation
3.0E-08
541250
1121000

Velocity (m/s)

2.5E-08
2.0E-08
1.5E-08
1.0E-08
5.0E-09
0.0E+00
0

0.2

0.4

0.6

0.8

1

y/D

Figure 4-2: Velocity magnitude along the center of vitreous chamber for 541,250 and
1,121,000 hexahedral cells
To demonstrate grid independence, simulations are run with 541,250 cells and
1,121,000 cells. Figure 4-2 shows the velocity plot along the centerline of the anterior
chamber for 541,250 cells and 1,121,000 cells. As seen in Fig. 4-2, less than 1 %
variation in the magnitude of the maximum velocity is observed between the 541,250 cell
calculation and the 1121,000 cell calculation. This good agreement between the solutions
from the two grid levels justifies the use of 541,250 cells for the simulation.
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Figure 4-3: Concentration contours (a) Current model, (b) Concentration along the center
of the vitreous chamber comparison with Friedrich et al. [65]
As a further validation of the numerical model, the results are compared with the
predictions of Friedrich et al. [65] who carried out a finite element analysis to predict the
concentration of injected at different locations in vitreous chamber for phakic and
aphakic eyes. In the study carried out by Friedrich et al. [65], vitreous was assumed to be
stagnant, i.e., effects of convection were neglected. The permeability of retinal surface is
considered to be 1E-7 cm/s and the drug injection volume is considered to be 15 µL. For
the present validation, the central injection case was considered and the diffusion
coefficient of drug was considered to be 5.6 E-10 m2/s [65]. Figure 4-3(a) shows the
concentration contours for the half section of the vitreous chamber for the current model.
As seen in Fig. 4-3(b), the current prediction of the concentration along the center of
vitreous chamber agrees well with the results obtained by Friedrich et al. [65].
4.3.2 Steady Flow Results

The first step in the simulation process was the determination of the pressure and
the velocity profiles within the vitreous at steady state. The liquid vitreous case was
compared with the predictions in which vitreous was modeled as a porous medium as in
Xu [38]. In the case of vitrectomy, as mentioned above, the vitreous is removed
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completely along with the collagen fibers and is replaced with different vitreous
substitutes. Therefore, for these cases the vitreous cannot be modeled as a porous
medium and has to be treated as a liquid.
4.3.2.1 Pressure Contour
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Figure 4-4: Pressure contour (a) Vitreous modeled as porous medium (b) Vitreous
modeled as liquid (water), (c) Pressure plot along the center of the vitreous chamber and
(d) Pressure plot along the circumference of the retinal surface
Figure 4-4(a) shows the pressure distribution for the cases where the vitreous is
modeled as a porous medium and Fig. 4-4(b) shows the corresponding pressure
distribution with the vitreous modeled as a fluid (water). The higher pressure specified at
the hyaloid membrane drives the aqueous from the hyaloid to the sclera, which is
maintained at a venous pressure of 1200 Pa. When the vitreous is considered as a porous
medium, there is a pressure drop of about 180 Pa across the vitreous humor [Fig. 4-4(c-
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d)]. These results are consistent with the earlier results obtained by Xu [38]. In the case of
a liquid vitreous, as seen in the Fig. 4-4(b), the vitreous humor is at a uniform pressure of
2000 Pa and the pressure drop essentially occurs across the retinal and the scleral tissues.
This implies that the entire retina and the lens are at higher pressure relative to the porous
media case. These higher pressures on the lens surface may be responsible for the
reported cataract complications occurring after vitrectomy [54, 61].
4.3.2.2 Velocity Contour
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Figure 4-5: Velocity magnitude plots (a, b) Contour plot of velocity magnitudes for
vitreous modeled as (a) porous medium (b) liquid (water), (c) Velocity along the center–
line of the vitreous chamber, (d) zoomed view of the encircled region in Fig. 4-5(c).
Figure 4-5 shows the predicted velocity profile within the vitreous chamber for
water and silicone oil as vitreous substitutes. Velocity magnitudes in the posterior
segment are very low and are smaller than 0.009 µm/s. However, as shown later, for low
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diffusivity drugs, convective effects can be important. Therefore, it is important to study
the behavior of the flow distribution within the vitreous chamber.
Figures 4-5(a) and 4-5(b) shows the path-lines superimposed on the velocity
magnitude contour for the porous-media vitreous and the liquid vitreous respectively. The
path-lines for both the cases are nearly identical with the flow directed from the hyaloid
membrane to the retinal surface. The velocity magnitudes are lower for the porous
medium due to higher flow resistance and appear to have a flatter distribution in the xdirection. Figs. 4-5(c) and 4-5(d) show the velocity magnitude along the centerline of the
vitreous chamber for different vitreous substitutes. The peak velocity location in the case
of porous medium is shifted upwards towards the lens compared to the cases with
vitreous fluids since the porous medium acts as a momentum sink and rapidly decelerates
the flow. When compared to the case of water as vitreous substitute, it is seen that there is
a 25% decrease in the peak velocity with the porous medium. Silicone oil has higher
dynamic viscosity compared to water (approx. order of 103 higher), as a result of which,
silicone oil has considerably lower velocity (approx. order of 103 lower) compared to the
other two cases. As seen later, this huge variation in velocity plays a major role in the
drug distribution within the vitreous chamber.
4.3.3 Concentration Contours
4.3.3.1 Direct Injection

Results will be first presented for direct injection technique of drug injected into
water and silicone oil. With direct injection technique, the drug is released
instantaneously from a pre-defined volume as shown in Fig 4-1(b). Retinal hydraulic
conductivity for small molecule drugs e.g., gentamicin, fluorescein, etc., has been
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reported to be 2.6e-5 cm/s [34]. To analyze the effects of low diffusion co-efficient, two
different drugs are studied (1) FITC-Dextran with D=3.9 E-11 m2/s and (2) Antibody
with D=1 E-11 m2/s. To show the effects of diffusion co-efficient, for low diffusion coefficient drugs the retinal permeability is fixed and the drug diffusion co-efficient is
varied. Retinal hydraulic conductivity for large molecule drugs e.g., FITC-Dextran has
been reported to be 1e-8 cm/s [77].
Figure 4-6 shows the contour plots for the concentration of the drug on the central
plane of the vitreous chamber at time t=100 hrs after the drug is released. At this time
instance, the drug has reached the retinal surface, and a fraction of the drug has crossed
the retinal interface entering the aqueous veins. Qualitatively, the numerical results
obtained by current model are comparable to the experimental results obtained by Araie
[34] for rabbit eye. The results cannot be exactly comparable because the volume of
rabbit vitreous is 1.46 mL whereas for human eye is 4mL. For high diffusion co-efficient
drugs [Fig. 4-6(a-b)], the concentration contour lines are parallel to the retina, which
implies that the flux of fluorescein across the retinal surface was the main route of drug
elimination. For highly viscous vitreous substitutes like silicone oil, where velocities are
lower, the drug is transported across the retinal layer more slowly compared to water.
Thus, as seen in Fig. 4-6(b), at t=100 hrs, a higher amount of drug is still present for the
case of silicone oil compared to water where, due to the higher transport rates, a
significant fraction of the drug has already crossed the retinal boundaries. Figure 4-6(c-d)
shows the concentration contours of the drugs with low diffusion coefficient, D=3.9 E-11
m2/s (e.g., FITC-Dextran) at time t=100 hrs after injection. In this case, as the diffusion
coefficient of the drug is lower, the diffusive transport of the drug is reduced in the
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Figure 4-6: Concentration contours at time t=100 hrs: (a) Water for D=6e-10 m2/s, (b)
Silicone oil for D=6e-10 m2/s, (c) Water for D=3.9e-11 m2/s, (d) Silicone oil for D=3.9e11 m2/s, (e) Water for D=1e-11 m2/s and (f) Silicone oil for D=1e-11 m2/s.
vitreous chamber. For low diffusion co-efficient drugs, the concentration contour lines
are perpendicular to both retina and lens boundaries along their entire length, indicating
that the flux across these surfaces was negligible whereas the concentration contour lines
were almost parallel to the hyaloid membrane, indicating that the diffusional flux was
normal to this tissue. This is in contrast to the higher diffusivity drug case in Fig. 4-6(a-b)
where the concentration lines are parallel to the retinal surface. For the drugs with D=1e104

11 m2/s [Fig. 4-6(e-f)], the retinal permeability is kept constant K=1e-8 cm/s. As seen,
with the decrease in diffusion co-efficient by 4 times the drug distribution becomes more
localized. At this time it is seen that for water [Fig. 4-6(e)], most of the drug
concentration has reached the lower retinal surface and the concentration levels have
diminished or disappeared in the upper half of the vitreous chamber. This, in turn, implies
that nearly all the drug is transported through the lower portion of the retinal surface. In
Fig. 4-6(f), it is seen that for silicone oil, the peak concentration of drug is still at the drug
injection site (due to the low transport rates), and that the iso-concentration lines are
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Figure 4-7: Concentration plot at the center of the retinal surface (a) D=6e-10 m2/s and
(b) D=3.9e-11 m2/s and D=1e-11 m2/s
Figure 4-7 shows the concentration plot of the drug at the center of retinal surface
with respect to time for water and silicone oil as vitreous fluids. It is seen that, the
concentration of the drug reaching the center of retina increases quickly after the
injection and then decays as the drug is transported across the surface of the retina. For
high diffusion co-efficient drugs [Fig. [4-7(a)], the drug reaches the maximum
concentration at time t=4.6 hrs which is in agreement with the numerical analysis carried

105

out by Friedrich et al. [37]. For highly viscous vitreous substitutes like silicone oil, where
velocities are lower, the drug is transported across the retinal layer more slowly compared
to water. It is seen that [Fig. 4-7(b)] decreasing the drug diffusivity through the vitreous
increases the time required for the drug molecules to travel from the drug injection site to
an elimination boundary. The concentration of the drug reaching the center of retinal
surface increases quickly for drugs with D=3.9 e-11 m2/s after the injection compared to
drugs with lower diffusion coefficient D=1e-11 m2/s and then decays as the drug is
transported across the lower surface of the retina. For drugs with D=3.9 e-11 m2/s for the
case of water, the concentration reaches the highest value of 0.5373 Kg/m3 at about t=56
hrs whereas for lower diffusion co-efficient drugs D=1e-11 m2/s the drug reaches the
maximum concentration of 0.979 Kg/m3 at time t=166 hrs. Here it is seen that with
decrease in diffusion co-efficient by approximately 4 times the time required to reach the
maximum concentration increases by 66% while the concentration increases by 45 %.
Similarly, for silicone oil with D=3.9 e-11 m2/s, the concentration of the drug reaches the
highest value of 0.4012 Kg/m3 at time t=64 hrs whereas for lower diffusion co-efficient
drug i.e., D=1e-11 m2/s the drug reaches the maximum concentration of 0.4024 Kg/m3 at
time t=256 hrs. For the case of silicone oil it is seen that there is hardly any increase in
the peak concentration but the time required for the drug to reach the maximum
concentration increases by 75 %.
The higher decay rates for water reflect the greater role of convection in this case.
In contrast, the time required to reach the peak retinal concentrations for silicone oil is
increased by a factor of approx. 1.5. Therefore, drug-retention in the vitreous chamber is
significantly enhanced with silicone vitreous substitutes. These significantly different
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drug distributions in space and time for different vitreous fluids underscore the relative
importance of understanding drug-vitreous fluid interactions before making decisions on
appropriate therapy.
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Figure 4-8: Concentration line plot along the center of the vitreous chamber at t=100 hrs
Figure 4-8 shows the concentration plot along the centerline of the vitreous
chamber at t=100 hrs. The peak concentration of the drug, for drugs with D=3.9 e-11
m2/s, is shifted towards the retinal surface (y/D=1) whereas for drugs with D=1e-11 m2/s
the peak concentration of the drug has still not reached the retinal surface. For drugs with
D=1e-11 m2/s, for water as the vitreous substitute the peak concentration is slightly
shifted towards the retinal surface. This observation can be analyzed using the Péclet
number defined as Pe =

v
where v is the average velocity along the centre of
D/d

vitreous chamber, d is the characteristic length and D is the diffusivity of the drug in the
vitreous. Péclet number greater that 1 indicates that transport by pressure-induced
convective flow is important. For water with D=1e-11 m2/s, Péclet number is 12.54,
indicating that convection is the primary mode of drug delivery. For silicone oil with
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D=1e-11 m2/s, Péclet number is 0.01216 which indicates that diffusion is the primary
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Figure 4-9: (a) Concentration line plot along the circumference of retinal surface at time
t=10 hrs and (b) zoomed view of the encircled region in Fig. 4-9(a)
Figure 4-9 shows the concentration of the drug along the circumferential surface
of the retinal surface at t=10 hrs. As the problem is symmetrical, the results are plotted
only for the one half section of the retinal surface. For water and silicone oil, with drug
diffusion co-efficient D=3.9 e-11 m2/s, drug quickly reaches the maximum concentration
compared to drug with lower diffusion coefficient. As seen, concentrations are highest at
the center of the retinal surface, but approximately 6% of the peak concentration of the
drug reaches the anterior portion of retinal surface i.e., at S=0. At this time, there is
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approximately 6 orders of decrease in magnitude of drug reaching the retinal surface for

3

Concentration (Kg/m )

the case of D=1e-11 m2/s compared to drug with D=3.9e-11 m2/s.
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Figure 4-10: Concentration line plot along the circumference of retinal surface at time
t=100 hrs
Figure 4-10 shows the concentration of the drug along the circumferential surface
of the retinal surface at t=100 hrs. In the case of water with D=3.9 E-11 m2/s, the drug
reaches the maximum concentration of 4.61E-01 Kg/m3 where as for silicone oil as
vitreous substitute the drug reaches the maximum concentration of 3.77E-01 Kg/m3. Due
to increased effects of convection in the case of water approximately 18 % increased
amount of drug reaches the retinal surface. For silicone oil, due to the dominance of
diffusion, it is seen that approximately 68% more amount of drug reaches the anterior
surface of retina when compared to water as vitreous substitute. Moreover at this time, it
is seen that for water with D=1e-11 m2/s, the drug reaches the maximum concentration of
7.09E-01 Kg/m3, where as for the drugs with same diffusion co-efficient maximum
concentration of 2.01E-01 Kg/m3 is attained with silicone oil as vitreous substitute.
Because of the higher effects of convection for water as vitreous substitute, it is seen that
there is approximately 71% increase in the amount of drug reaching the retinal surface.
When compared to the drugs with D=3.9e-11 m2/s, it is seen that there is approximately
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54 % increase in the amount of drug reaching the retinal surface. Moreover, when
comparing the amount of drug reaching the anterior surface of the retina, the
concentration is approximately zero for drugs with D=1 E-11 m2/s. This implies that
higher diffusion co-efficient drugs are more suitable if therapy is needed in the anterior
portion of the retinal surface.
To show the effects of different diffusion coefficient, the peak concentration
reaching the retinal surface and the time are tabulated in the Table 4-2.
Table 4-2: Maximum concentration and the corresponding residence time (Water)

(D=Diffusion coefficient of the drug, C=Maximum concentration reaching the centre of
the retina and t=Time required to reach the maximum concentration)
D (m2/s)
C (Kg/m3)
t (hr)
6 E-10
0.41122
4.6
3.9 E-11
0.5373
56
1 E-11
0.979
166
Table 4-2 shows the concentration of the drug at the center of retinal surface with
respect to time for water with drugs with different diffusion co-efficient. As seen the
decrease in the drug diffusion co-efficient increases the effects of convection and
moreover there is an increase in amount of drug reaching the retinal surface. For low
diffusion coefficient drugs, it is seen that there is approx. 45 % increase in the peak
concentration reaching the retinal surface.
Table 4-3: Maximum concentration and the corresponding residence time (Silicone Oil)

(D=Diffusion coefficient of the drug, C=Maximum concentration reaching the centre of
the retina and t=Time required to reach the maximum concentration)
D (m2/s)
C (Kg/m3)
t (hr)
6 E-10
0.3985
4.5
3.9 E-11
0.4012
64
1 E-11
0.4024
256
6 E-12
0.4029
436
1 E-12
0.405
2410
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Table 4-3 shows the concentration of the drug at the center of retinal surface with
respect to time for silicone oil with drugs with different diffusion co-efficient. As the
diffusion co-efficient of drug in silicone oil is unavailable, simulations for range of values
of diffusion co-efficient are carried out (i.e., from 6 E-10 m2/s to 1 E-12 m2/s). For
silicone oil as Pé number is less than 1, diffusion is the dominant mode of drug
distribution. It is seen in Table 4-3 that the peak concentration reaching the retinal surface
is approximately constant.
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0
0.0E+00
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1.0E+09
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Figure 4-11: Schmidt number VS time (Silicone Oil)
Figure 4-11 shows the variation of Schmidt number with the time required to
reach the peak concentration at the center of retinal surface. Schmidt number is
proportional to (kinetic viscosity) / (molecular diffusivity) i.e., Sc =

µ
. It is seen that
ρ .D

Schmidt number varies linearly with time, i.e., Decrease in the diffusion co-efficient of
the drug increases the time required to reach the peak concentration on the retinal surface.
4.3.3.2 Time-Released Drug Injection

Attention is turned next to the case where the drug is released as a function of
time from a pre-defined volume, as shown in the Fig. 4-1(b). The goal with time-released
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injection is to achieve non-toxic drug concentration levels on the retinal surface relatively
quickly, so that therapy is initiated shortly after drug injection, and to sustain suitable
levels of retinal concentrations over reasonable time duration to maximize the benefit of
the initial injection. In evaluating the time-released injection technique, we will make
comparisons with the direct injection technique discussed in the previous section. In both
cases, the same volume of drug was injected to enable this comparison.

Kg/m3

(a)

Kg/m3

(b)

Kg/m3

Kg/m3

(d)

(c)

Kg/m3

Kg/m3

(e)

(f)

Figure 4-12: Concentration contours at time t=300 hrs (a) Water for D=6e-10 m2/s, (b)
Silicone oil for D=6e-10 m2/s, (c) Water for D=3.9e-11 m2/s, (d) Silicone oil for D=3.9e11 m2/s, (e) Water for D=1e-11 m2/s and (f) Silicone oil for D=1e-11 m2/s.
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Figure 4-12 shows the concentration contours of the drugs with the higher
diffusion coefficient, D=6 E-10 m2/s, when injected into water and silicone oil. In this
case, transport rates are lower because of the lower diffusion coefficients, and therefore
compared to Fig. 4-6, the concentration distributions are more localized. Compared to
direct injection [Fig. 4-6], the peak concentrations are located further away from the
retinal surface since the drug is released at a slower rate. Due to lower retinal
permeability for large molecule drugs, as seen in Fig. 4-12(c-f), the concentration contour
lines are perpendicular to both retina and lens boundaries along their entire length,
indicating that the flux across these surfaces was negligible whereas the concentration
contour lines were almost parallel to the hyaloid membrane, indicating that the
diffusional flux was normal to this tissue which is in contrast to the higher diffusivity
drug case in Fig. 4-12(a-b) where the concentration lines are parallel to the retinal
surface. At t=300 hrs, Fig. 4-12(c,e) shows that for water, most of the drug concentration
has reached the lower retinal surface and the concentration levels have diminished or
disappeared in the upper half of the vitreous chamber. This, in turn, implies that nearly all
the drug is transported through the lower portion of the retinal surface. In Fig. 4-12(d,f),
it is seen that for silicone oil, the peak concentration of drug is still at the drug injection
site (due to the low transport rates), and that the iso-concentration lines are circular
(indicative of the dominance of diffusion).
Figure 4-13(a) shows the plot for the concentration of the high diffusion coefficient drug at the center of the retinal surface with respect to time for water and
silicone oil. These results are consistent with those shown in Fig. 4-7 for direct injection,
except that the time taken to reach the peak is longer and is nearly 2.8 days (67 hrs)
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instead of the 4.6 hrs for direct injection. Further, the decay rate of the retinal drug
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concentration is reduced considerably with the time-released option. Thus, the residence
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Figure 4-13: Concentration plot at the center of the retinal surface (a) D=6e-10 m2/s and
(b) D=3.9e-11 m2/s and D=1e-11 m2/s
time of the drug is longer (factor of 14.8) with time-released drugs compared to the case
of direct injection. When compared to direct injection, it is seen that in the case of timereleased drug injection with water as vitreous substitute only 0.15% of peak
concentration drug reaches center of the retinal surface. Thus, when controlled quantity
of the drug is required on the retinal surface over an extended period of time the Timereleased drug delivery is the desired option. Because of slower transport rates in the case
of silicone oil it is seen in Fig. 4-13(a) that peak concentrations of the drug are higher
(by 4 %), and decay rates are lower when compared to the case of water. For low
diffusion co-efficient drugs, it can be seen that for water with D=3.9 E-11 m2/s [Fig. 413(b)], the drug reaches the peak concentration of 0.00224 Kg/m3 at t=216 hrs whereas
for D=1 E-11 m2/s, the peak concentration attained is 0.005456 Kg/m3 at t=316 hrs.
Compared to direct injection for D=3.9 E-11 m2/s, residence times with time-released
injection is about 3.8 times longer with water as the vitreous fluid whereas for the drugs
with D=1 E-11 m2/s the residence time is 1.9 times longer. In contrast, as noted earlier,
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for the higher diffusion drug, residence times were nearly 14.8 times longer with timereleased injection. Therefore, the long residence time benefits of time-released injection
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decrease for lower diffusion coefficient drugs.
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Figure 4-14: Concentration line plot along the center of the vitreous chamber at t=400 hrs
Figure 4-14 shows the drug concentration along the center of the vitreous
chamber at t=400 hrs. The peak concentration has still not reached the retinal surface
since the drug is released slowly. The high concentration region in the center (in contrast
to Fig. 4-8 with direct injection) is a reflection of the time-released injection process. At
this time, a portion of the drug is still at the injection site or has been just released. As
seen in Fig. 4-14, for drugs with D=1 E-11 m2/s for water less amount of drug is available
at the drug injection position compared to silicone oil, as more amount of drug is swept

Concentration (Kg/m3)

away from the retinal surface due to increased effects of convection.
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Figure 4-15: Concentration line plot along the circumference of retinal surface at time
t=100 hrs
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Figure 4-15 shows the drug concentration along the retinal surface at t=100 hrs. It
is seen from the plot that the peak concentration for drugs with D=3.9 E-11 m2/s with
water as vitreous substitute is maximum followed by the drugs with D=1 E-11 m2/s.
Moreover, it is seen that for drugs with lower diffusion co-efficient i.e., D=1 E-11 m2/s,

3

Concentration (Kg/m )

the amount of drug reaching the anterior portion of retina is approximately zero.
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Figure 4-16: Concentration line plot along the circumference of retinal surface at time
t=400 hrs
Figure 4-16 shows the drug concentration along the retinal surface at t=400 hrs.
As seen, for drugs with D=1 E-11 m2/s for water as vitreous substitutes there is 41%
increase in the amount of the drug reaching the retinal surface compared to silicone oil.
For drugs with D=1 E-11 m2/s, due to higher effects of convection only 0.004% of drug
reaches the anterior portion of retina. This implies that lower diffusion co-efficient drugs
are more suitable if therapy is needed in the posterior portion of the retinal surface.
Moreover, for silicone oil with D=1 E-11 m2/s, due to higher effects of diffusion 9% of
the drug reaches the anterior portion of retina and for drugs with D=3.9 E-11 m2/s, 17 %
of the drug reaches the anterior portion of retina. This implies that higher diffusion coefficient drugs are more suitable if therapy is needed in the anterior portion of the retinal
surface.
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The results of the simulations carried out are summarized in Table 4-4. It is seen
that in time-released drug injection, where the drug is released as a function of time, drug
concentration levels are several orders of magnitudes lower than those of direct injection,
and dangers of retinal toxicity are avoided. Further, drug residence times are considerably
longer with time-released injection, being nearly 10-12 times greater for the higher
diffusion coefficient drug. In the case of direct injection of drugs with low diffusion
coefficient, the peak concentration levels of 0.979 Kg/m3 for water with D=1 E-11 m2/s is
quite high, and potentially can lead to retinal toxicity.
Table 4-4: Maximum concentration and the corresponding residence time

(D=Diffusion coefficient of the drug, C=Maximum concentration reaching the centre of
the retina and t=Time required to reach the maximum concentration)
Fluid
Injection Type
D (m2/s)
C (Kg/m3)
t (hr)
Water
Direct
6 E-10
0.41122
4.6
3.9 E-11
0.5373
56
1 E-11
0.979
166
Time-released
6 E-10
6.69E-4
67
3.9 E-11
0.00224
216
1 E-11
0.0054
316
Silicone Oil
Direct
6 E-10
0.3985
4.5
3.9 E-11
0.4012
64
1 E-11
0.4024
256
Time-released
6 E-10
6.9E-4
76
3.9 E-11
8.3E-4
810
1 E-11
4.48E-3
3480

4.4 Concluding Remarks

A three-dimensional computational strategy was developed to investigate drug
delivery in eyes after undergoing vitrectomy. The geometrical model adopted uses a
realistic representation of the retina and the sclera (modeled as porous layers with
specific hydraulic permeability), and predictions are obtained for both the flow-field and
the drug concentrations by solving the conservation equations for mass, momentum and
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drug concentrations. Results are presented for water and silicone oil as the vitreous fluid.
Two drug delivery techniques are considered: (a) direct injection, where the injected drug
is released instantaneously into the vitreous and (b) time-released injection of a drug,
where the drug is released in a specified time-dependent manner.
(1) The results show that the concentration distribution depends on the vitreous fluids,
permeability of retina and the diffusion co-efficient of the drug.
(2) Water as vitreous fluids exhibit higher drug transport rates than silicone oil. This
observation was related to convection effects which play a more important role in the
case of water. For silicone oil, convection effects are small, and diffusion is dominant.
(3) In the case of direct injection, for water as vitreous fluid, the retinal drug
concentration levels reach high values, even for low diffusivity drugs, and such situations
can lead to retinal toxicity.
(4) For drugs with high diffusion co-efficient uniform distribution of the drug is obtained
along the surface of the retina whereas for the low diffusion co-efficient drugs the
concentration of drug is localized along the posterior surface of the retina.
(5) Time-released injection is shown to provide considerably lower levels of drug
concentration along the retinal surface for sustained periods of time. This is likely to
reduce the local toxicity arising from high drug concentrations, and to provide sustained
therapy over a longer period of time compared to direct injection.
(6) For low diffusion coefficient drugs, due to higher effects of convection, the amount of
drug reaching the anterior portion of retina is approximately zero. This implies that
higher diffusion co-efficient drugs are more suitable if therapy is needed in the anterior
portion of the retinal surface.
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In future, the model will be extended to account for the choroid layer and the drug
adsorption in the choroid, and to include issues pertaining to drug metabolism, variation
in drug diffusion coefficient and retinal/choroid/sclera permeability, and the injection
location. These issues have been ignored in the present study.
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